Ophthalmology – Transient Visual Loss

What the Symptom Represents

Transient visual loss (TVL) is temporary impairment or loss of vision that subsequently returns toward baseline.

The first and most important distinction is whether the event was:

• Transient monocular visual loss (TMVL) — usually arising from the eye, retina, optic nerve, or ipsilateral anterior circulation
• Transient binocular visual loss (TBVL) — more often related to the visual cortex, posterior circulation, migraine, or seizure

TVL is a symptom, not a diagnosis.

In an older patient or anyone with vascular risk factors, sudden painless negative visual loss should be considered:

Retinal or cerebral ischemia until proven otherwise.

Why Determining Monocular vs Binocular Matters

Localization begins with whether one eye or both eyes were affected.

Monocular loss suggests

• Retina
• Optic nerve
• Ophthalmic artery
• Ipsilateral carotid circulation

Binocular loss suggests

• Occipital cortex
• Posterior cerebral circulation
• Migraine aura
• Seizure

However, patients frequently misidentify a:

Homonymous hemianopic defect as monocular vision loss.

Careful history is therefore essential.

A Practical Question to Ask

Ask the patient:

“Did you cover one eye during the episode and confirm the other eye was normal?”

If not, determine whether the loss may actually have affected:

• The right half of vision in both eyes
• The left half of vision in both eyes

which would suggest a:

Retro-chiasmal cerebral process.

Major Causes of Transient Monocular Visual Loss

Important causes include:

• Retinal ischemia / retinal TIA
• Carotid atherosclerotic embolism
• Cardioembolism
• Giant cell arteritis
• Carotid artery dissection
• Retinal vasospasm
• Ocular ischemic syndrome
• Papilledema
• Optic disc drusen
• Intermittent angle closure
• Tear-film or corneal surface abnormalities
• Vitreous opacity moving across the visual axis

Major Causes of Transient Binocular Visual Loss

Important causes include:

• Migraine aura
• Posterior circulation ischemia
• Occipital seizure
• Severe systemic hypotension
• Papilledema-related obscurations
• Less commonly bilateral ocular causes

Retinal TIA – The Most Important Vascular Cause

A transient retinal ischemic event may result from:

• Carotid plaque embolization
• Cardiac embolism
• Hypoperfusion
• Arterial dissection
• Vasculitis

The classic description is:

Sudden, painless, negative monocular vision loss

often described as:

• Curtain
• Shade
• Gray-out
• Black-out
• Altitudinal loss

with spontaneous recovery over minutes.

Amaurosis Fugax – Modern Usage

The traditional term:

Amaurosis fugax

usually refers to transient monocular vision loss from retinal or optic nerve ischemia.

Because the term does not specify mechanism, it is often more useful clinically to say:

Ischemic transient monocular visual loss or retinal TIA.

Why Retinal Ischemia Is a Stroke Warning

Retinal transient ischemia and cerebral TIA share many of the same causes and vascular risks.

Therefore suspected ischemic TMVL requires:

Urgent stroke-style evaluation

rather than routine outpatient observation.

The concern is not merely future ocular damage but:

• Cerebral stroke
• Myocardial infarction
• Other vascular events

Important Vascular Risk Factors

Risk increases with:

• Age
• Hypertension
• Diabetes mellitus
• Hyperlipidemia
• Cigarette smoking
• Atrial fibrillation
• Carotid atherosclerosis
• Coronary artery disease
• Prior stroke or TIA

Carotid Atherosclerotic Disease

Ipsilateral carotid plaque can cause TMVL through:

• Artery-to-artery embolism
• Severe flow limitation
• Both

Transient symptoms may be triggered by systemic hypotension when carotid stenosis is severe.

Retinal Emboli

Funduscopic examination may occasionally reveal embolic material.

Cholesterol Embolus

Hollenhorst plaque

appears:

• Yellow-orange
• Refractile
• Usually at an arteriolar bifurcation

Often arises from:

• Carotid atherosclerosis
• Aortic arch disease

Platelet-Fibrin Embolus

Usually:

• Gray-white
• Less refractile
• Elongated

Calcific Embolus

Typically:

• White
• Larger
• More rounded
• Often associated with calcific cardiac valve disease

Cardioembolic Causes

Possible sources include:

• Atrial fibrillation
• Left ventricular thrombus
• Valvular disease
• Endocarditis
• Intracardiac tumor
• Mechanical valve
• Recent myocardial infarction

A normal single ECG does not exclude:

Paroxysmal atrial fibrillation.

Carotid Artery Dissection

Consider carotid dissection particularly in:

• Younger patients
• Recent neck trauma
• Chiropractic manipulation
• Sudden neck rotation
• Spontaneous painful Horner syndrome

Clues include:

• Ipsilateral headache or neck pain
• Partial Horner syndrome
• TMVL
• Contralateral neurologic deficits

CTA or MRA of the head and neck is usually required.

Giant Cell Arteritis

In patients typically older than 50 years, transient monocular visual loss may precede permanent:

• Central retinal artery occlusion
• Arteritic anterior ischemic optic neuropathy

Ask specifically about:

• New headache
• Scalp tenderness
• Jaw claudication
• Polymyalgia symptoms
• Constitutional symptoms
• Diplopia

Why GCA Must Be Treated Immediately

If GCA is strongly suspected:

High-dose corticosteroid treatment should begin immediately.

Do not delay treatment while waiting for:

• ESR
• CRP
• Temporal artery ultrasound
• Temporal artery biopsy

The goal is to protect the:

Fellow eye and cerebral circulation.

Laboratory Evaluation for Suspected GCA

Useful initial tests include:

• ESR
• CRP
• CBC with platelet count

Normal inflammatory markers make GCA less likely but do not absolutely exclude it.

Papilledema-Related Transient Visual Obscurations

Papilledema commonly produces episodes lasting:

Seconds

rather than many minutes.

Patients often describe:

• Gray-out
• Black-out
• Brief blur

Episodes may be triggered by:

• Standing
• Bending
• Valsalva
• Head movement

These are termed:

Transient visual obscurations.

Optic Disc Drusen

Buried or visible optic disc drusen can also produce:

• Brief obscurations
• Peripheral visual field defects

Drusen may mimic optic disc edema.

Useful testing includes:

• EDI-OCT
• Fundus autofluorescence
• B-scan ultrasonography in selected cases

Ocular Surface Disease

One of the most common benign explanations for intermittent blur is:

Tear-film instability.

Clues include:

• Fluctuating vision
• Burning
• Dryness
• Improvement after blinking

This differs markedly from abrupt vascular visual loss.

Intermittent Angle Closure

Episodes may produce:

• Blurred vision
• Halos around lights
• Ocular pain
• Headache
• Nausea

The eye may appear normal between attacks.

Gonioscopy or anterior segment assessment is needed when suspected.

Retinal Vasospasm

Retinal arterial vasospasm can occasionally cause recurrent TMVL, especially in younger individuals.

However:

Retinal migraine is a diagnosis of exclusion.

A vascular or inflammatory cause should not be dismissed simply because the patient has migraine.

Important Modern Correction About “Retinal Migraine”

True retinal migraine is:

Rare.

Migraine aura usually originates in the visual cortex and therefore produces:

Binocular homonymous visual phenomena, even if the patient perceives them as affecting one eye.

Migraine Aura

Migraine is a common cause of transient binocular visual symptoms.

Typical features include:

• Positive visual phenomena
• Gradual evolution
• Expanding scintillating scotoma
• Zigzag or fortification pattern
• Movement across the visual field

Symptoms usually evolve over:

5–60 minutes.

Positive vs Negative Visual Phenomena

Positive phenomena

Examples:

• Flashing
• Sparkling
• Zigzags
• Colored patterns
• Scintillation

These favor:

Migraine or seizure

but can occasionally occur with ischemia.

Negative phenomena

Examples:

• Curtain
• Gray-out
• Missing area
• Complete blackout

These raise greater concern for:

Ischemia.

Migraine Aura Without Headache

Visual migraine aura may occur:

• Before headache
• During headache
• Without headache

The latter is sometimes termed:

Typical aura without headache.

New first-onset aura in an older patient should not automatically be attributed to migraine without appropriate vascular evaluation.

Occipital Seizure

Visual seizures may cause:

• Bright colored shapes
• Repetitive flashing
• Small circular or geometric hallucinations
• Rapid onset and offset

They are often:

Shorter and more stereotyped than migraine aura.

Associated features may include:

• Altered awareness
• Eye or head deviation
• Motor activity
• Postictal confusion

Posterior Circulation Ischemia

Transient binocular visual loss can result from:

Occipital lobe ischemia due to vertebrobasilar disease.

Associated symptoms may include:

• Vertigo
• Diplopia
• Dysarthria
• Ataxia
• Facial numbness
• Limb weakness or numbness

These neurologic symptoms strongly support:

Posterior circulation TIA.

Vertebral Artery Dissection

Consider vertebral dissection when TBVL or posterior circulation symptoms follow:

• Neck trauma
• Sudden neck movement
• Manipulation

Typical associated symptoms include:

• Posterior neck pain
• Occipital headache
• Vertigo
• Ataxia
• Diplopia

CTA or MRA is appropriate.

Hypotension and Hypoperfusion

Systemic hypotension can cause visual symptoms in patients with:

• Critical carotid disease
• Severe posterior circulation disease
• Ocular ischemic syndrome

Episodes may be provoked by:

Standing or exertion.

Ocular Ischemic Syndrome

Severe carotid occlusive disease can produce chronic ocular hypoperfusion.

Findings may include:

• Midperipheral retinal hemorrhages
• Dilated but non-tortuous retinal veins
• Narrow retinal arteries
• Anterior chamber inflammation
• Iris neovascularization
• Low IOP in some patients

Light-induced visual loss may occur because increased photoreceptor metabolic demand cannot be met by the compromised circulation.

Central Retinal Vein Occlusion and Transient Symptoms

Impending or evolving retinal vein occlusion can occasionally cause transient blur.

However, classic CRVO usually produces:

Persistent rather than truly transient visual loss.

Pregnancy and Hypercoagulability

Pregnancy alters coagulation and vascular physiology.

TVL during pregnancy requires consideration of:

• Migraine
• Preeclampsia
• Retinal vascular occlusion
• Cerebral venous thrombosis
• Posterior reversible encephalopathy syndrome

Associated:

• Hypertension
• Headache
• Neurologic symptoms

require urgent assessment.

Medication and Drug History

Ask about:

• Oral contraceptives
• Hormonal therapy
• Vasoconstrictive medications
• Anticoagulants
• Illicit drugs

Particularly relevant substances include:

Cocaine and amphetamines

because they can cause severe vasoconstriction and vascular events.

The Most Important History Feature – Time Course

Duration can provide useful localization.

Seconds

Suggest:

• Papilledema
• Optic disc drusen
• Tear-film abnormality

Several minutes

Raises concern for:

• Retinal or cerebral ischemia

5–60 minutes with gradual evolution

More typical of:

• Migraine aura

These are patterns, not absolute rules.

Why “Curtain Coming Down” Matters

A sudden curtain or shade across one eye is a classic description of:

Retinal ischemia

but retinal tear or detachment can also be described similarly.

Associated:

• Flashes
• New floaters

should prompt urgent examination for a retinal break or detachment.

Examination During or After the Episode

A complete ophthalmic assessment should include:

• Visual acuity
• Pupils
• Color vision
• Confrontation fields
• Motility
• Slit-lamp examination
• IOP
• Dilated retinal examination

The examination may be:

Completely normal between ischemic attacks.

A normal eye examination therefore does not exclude retinal TIA.

RAPD

An RAPD may occur if there has been persistent asymmetric injury to:

• Retina
• Optic nerve

But in a purely transient episode with complete recovery:

The pupil examination may be normal.

Visual Field Testing

Formal perimetry is useful when:

• Symptoms persist
• A neurologic field defect is suspected
• Optic nerve disease is possible

A homonymous defect points toward:

Retro-chiasmal disease.

Urgent Evaluation of Suspected Ischemic TMVL

Current practice increasingly evaluates acute retinal ischemic symptoms similarly to cerebral TIA.

Workup may include:

• Brain MRI with diffusion-weighted imaging
• CTA or MRA of head and neck
• Carotid imaging
• ECG
• Cardiac monitoring
• Vascular risk assessment

The exact pathway depends on local stroke services.

Carotid Imaging

Options include:

• Carotid duplex ultrasound
• CTA
• MRA

CTA or MRA is particularly useful when evaluating:

• Dissection
• Intracranial vascular disease
• Complex stenosis

Brain MRI

MRI with diffusion-weighted imaging can identify:

Clinically silent acute cerebral infarction

in some patients presenting with retinal ischemia.

This finding may significantly alter:

• Risk classification
• Secondary prevention

Cardiac Evaluation

Depending on presentation, evaluation may include:

• ECG
• Telemetry
• Ambulatory rhythm monitoring
• Echocardiography

Longer rhythm monitoring may detect:

Paroxysmal atrial fibrillation missed on a single ECG.

Echocardiography

Transthoracic echocardiography may identify:

• Ventricular thrombus
• Structural heart disease
• Severe valve pathology

Transesophageal echocardiography is reserved for selected cases when there is concern for:

• Aortic arch disease
• Valvular lesions
• Intracardiac shunt

Hypercoagulable Testing

A broad thrombophilia panel should not routinely be ordered for every patient with TMVL.

Testing is more appropriate in selected patients with:

• Young age
• Recurrent thrombosis
• Personal or family history of thrombosis
• Unusual vascular events
• No conventional vascular explanation

Potential testing may include:

• Antiphospholipid antibodies
• Factor V Leiden
• Prothrombin mutation
• Protein C/S
• Antithrombin deficiency

depending on context.

Fluorescein Angiography

FA is not routinely required after every transient episode.

It may be useful when there is concern for:

• Retinal hypoperfusion
• Ocular ischemic syndrome
• Retinal vascular occlusion
• Choroidal perfusion abnormality

The First Management Principle

Treatment is directed at the:

Underlying cause.

There is no single medication for “transient visual loss.”

Suspected Retinal TIA

Management generally includes urgent vascular secondary prevention such as:

• Antiplatelet therapy when appropriate
• High-intensity statin therapy when indicated
• Blood-pressure optimization
• Diabetes management
• Smoking cessation

Specific treatment should follow stroke/TIA evaluation and identified mechanism.

Antiplatelet Therapy

For non-cardioembolic retinal TIA, antiplatelet therapy commonly includes:

• Aspirin
• Clopidogrel

Short-term dual antiplatelet therapy may be appropriate in selected high-risk TIA patients according to current stroke protocols.

It is not automatically appropriate for every cause of TVL.

Cardioembolic Disease

When atrial fibrillation or another high-risk cardioembolic source is identified:

Anticoagulation

is generally preferred over antiplatelet therapy for stroke prevention.

For most patients with nonvalvular AF:

Direct oral anticoagulants (DOACs) are now preferred over warfarin unless a specific contraindication exists.

Important Modern Correction About Dissection

Older teaching routinely recommended:

IV heparin followed by warfarin

for carotid or vertebral dissection.

Current evidence supports either:

• Antiplatelet therapy
• Anticoagulation

for many patients, individualized according to:

• Imaging
• Ischemic burden
• Bleeding risk
• Specialist assessment

Routine anticoagulation is no longer mandatory.

Carotid Endarterectomy

For symptomatic ipsilateral carotid stenosis:

Carotid endarterectomy provides clear benefit in appropriate patients with severe 70–99% stenosis.

It may also benefit selected patients with:

50–69% stenosis

depending on:

• Age
• Sex
• Comorbidity
• Surgical risk
• Timing
• Anatomy

Modern treatment also includes intensive medical risk-factor control.

Why Timing of Carotid Surgery Matters

When indicated after a TIA or nondisabling ischemic event, carotid intervention is generally most beneficial when performed:

Promptly, often within approximately 2 weeks

once the patient is neurologically and medically appropriate.

Giant Cell Arteritis Treatment

Suspected GCA with visual symptoms requires:

Immediate high-dose systemic corticosteroids.

IV methylprednisolone may be used when there is:

• Acute visual loss
• Fellow-eye threat
• Other severe ischemic manifestations

Temporal artery testing should follow without delaying treatment.

Migraine Management

Typical recurrent migraine aura without vascular warning features may be managed with:

• Trigger management
• Acute migraine treatment
• Preventive therapy when frequent

But first-time visual aura or a major change in aura pattern, particularly in an older patient, deserves evaluation for:

Vascular or structural causes.

Seizure Management

Suspected occipital epilepsy may require:

• Neurologic consultation
• EEG
• Brain imaging

Antiseizure medication is used when the diagnosis is established.

Papilledema Management

Transient obscurations from papilledema require treatment of the:

Underlying raised intracranial pressure

rather than treatment of the brief visual episodes themselves.

This may require:

• Neuroimaging
• Venous imaging
• Lumbar puncture when safe and indicated
• Cause-specific therapy

Surface-Related Visual Fluctuation

Tear-film related episodes usually respond to:

• Preservative-free artificial tears
• Treatment of meibomian gland dysfunction
• Management of exposure or ocular surface disease

Rapid improvement after blinking is a useful diagnostic clue.

Red Flags Requiring Emergency Assessment

Urgent evaluation is appropriate for:

• Sudden painless monocular blackout
• New binocular visual loss with neurologic symptoms
• TMVL in a patient with vascular risk factors
• Suspected GCA
• Neck trauma with Horner syndrome or neurologic symptoms
• New visual symptoms with atrial fibrillation
• Persistent retinal artery occlusion
• Visual symptoms associated with weakness, numbness, aphasia, ataxia, or dysarthria

Important Modern Correction About Younger Patients

Older texts often suggested that TMVL in patients younger than approximately 45 years is usually benign.

This is:

Too broad and potentially unsafe.

Young patients have lower atherosclerotic risk but can still have:

• Carotid dissection
• Cardioembolism
• Hypercoagulable disorders
• Vasculitis
• Migraine
• Retinal vascular disease

Age should modify the differential, not end the evaluation.

Expected Outcome

Prognosis depends entirely on the underlying cause.

Episodes from:

• Migraine
• Tear-film disease
• Benign transient obscurations

may carry little permanent ocular risk.

Ischemic TMVL, however, can be a warning of:

• Stroke
• Permanent retinal artery occlusion
• Myocardial infarction

and therefore requires rapid recognition.

High-Yield Takeaways

• Transient visual loss is a symptom, not a diagnosis; the first task is to determine whether it was monocular or binocular.
• Sudden painless monocular negative visual loss should be treated as retinal ischemia/TIA until proven otherwise, particularly in patients with vascular risk factors.
• Patients frequently mistake a homonymous binocular field defect for monocular loss, so localization must be clarified carefully.
• Ischemic TMVL is classically described as a curtain, shade, gray-out, or blackout lasting minutes.
• Papilledema and optic disc drusen typically cause very brief transient visual obscurations lasting seconds.
• Migraine aura usually produces gradually evolving positive binocular phenomena over approximately 5–60 minutes.
• True retinal migraine is rare and is a diagnosis of exclusion.
• Transient binocular loss associated with vertigo, diplopia, dysarthria, ataxia, or weakness raises concern for posterior circulation TIA.
• Carotid dissection should be suspected with TMVL plus ipsilateral headache/neck pain or Horner syndrome, especially after trauma or neck manipulation.
• In patients over 50, TMVL with headache, jaw claudication, scalp tenderness, or polymyalgia symptoms requires urgent evaluation for giant cell arteritis.
• A normal eye examination between attacks does not exclude retinal TIA.
• Suspected ischemic TMVL warrants urgent brain and vascular imaging, cardiac evaluation, and vascular risk assessment, often through a stroke/TIA pathway.
• Routine broad thrombophilia testing is not indicated for every patient; reserve it for selected younger or otherwise unexplained cases.
• Non-cardioembolic retinal TIA is generally managed with antiplatelet therapy and aggressive vascular risk reduction, while atrial fibrillation usually requires anticoagulation.
• For most nonvalvular atrial fibrillation, DOACs are preferred over warfarin unless contraindicated.
• Carotid or vertebral dissection may be treated with either antiplatelet therapy or anticoagulation; routine heparin-to-warfarin treatment is no longer obligatory.
• Appropriate patients with symptomatic 70–99% carotid stenosis generally benefit from prompt carotid endarterectomy; selected patients with 50–69% stenosis may also benefit.
• TMVL in younger patients should not automatically be labeled benign.
• The crucial clinical principle is: transient retinal ischemia may leave no ocular sign after the episode but can be an early warning of an impending stroke.

Ophthalmology – Trachoma

What the Disease Represents

Trachoma is a chronic keratoconjunctivitis caused by repeated ocular infection with:

Chlamydia trachomatis serovars A, B, Ba, and C.

It remains an important preventable cause of blindness in some endemic communities.

The disease has two broad phases:

• Active inflammatory trachoma, mainly affecting young children
• Cicatricial trachoma, developing years later after repeated infections

The sight-threatening sequence is:

Recurrent conjunctival infection → tarsal scarring → entropion/trichiasis → repeated corneal trauma → corneal opacity → blindness

Where Trachoma Persists Today

The global burden has fallen substantially because of large-scale control programs.

Trachoma now persists mainly in communities with:

• Poverty
• Limited access to clean water
• Poor sanitation
• Household crowding
• Inadequate access to eye care

The greatest remaining burden is concentrated predominantly in parts of:

• Sub-Saharan Africa
• Some areas of the Middle East
• Selected regions of Asia and the Pacific

Many countries that were historically endemic have now achieved elimination of trachoma as a public health problem.

Who Is Most Affected

Active Trachoma

Most common in:

Children approximately 1–9 years old

Young children act as an important reservoir of ocular infection.

Cicatricial Disease

Scarring and trichiasis are more common in:

• Adults
• Older individuals
• Women in endemic communities

Women may have greater cumulative exposure because of close contact with infected children.

How Infection Spreads

Transmission occurs through infected ocular or nasal secretions.

Important routes include:

• Direct eye-to-hand-to-eye contact
• Contaminated fingers
• Shared towels or cloths
• Fomites
• Eye-seeking flies, particularly Musca sorbens

Respiratory spread through coughing or sneezing is not considered a major transmission pathway.

Why Sanitation Matters

Eye-seeking flies breed particularly well where there is:

Exposed human feces.

Therefore:

• Latrine access
• Waste disposal
• Facial cleanliness
• Water availability

are central components of trachoma control.

How Repeated Infection Produces Blindness

A single infection usually does not cause blindness.

The problem is:

Repeated episodes of conjunctival infection and inflammation over many years.

This produces:

1. Chronic follicular conjunctivitis
2. Subepithelial fibrosis
3. Tarsal conjunctival scarring
4. Eyelid distortion
5. Entropion
6. Trichiasis
7. Repeated corneal epithelial injury
8. Secondary infection and vascularization
9. Permanent corneal opacity

What Happens Microscopically

Active disease shows:

• Chlamydial infection of conjunctival epithelial cells
• Lymphoid follicles
• Chronic inflammatory-cell infiltration

Repeated inflammation produces:

• Goblet-cell loss
• Squamous metaplasia
• Subepithelial fibrosis
• Conjunctival shortening

This eventually transforms an infectious conjunctivitis into a:

Cicatrizing ocular-surface disease.

The WHO Simplified Grading System

Trachoma is commonly classified clinically using five signs:

TF, TI, TS, TT, and CO

TF – Trachomatous Inflammation, Follicular

Defined by:

Five or more follicles, each at least 0.5 mm, in the central upper tarsal conjunctiva.

This is the principal clinical sign used in population surveys of active trachoma.

TI – Trachomatous Inflammation, Intense

There is pronounced inflammatory thickening of the upper tarsal conjunctiva such that:

More than half of the normal deep tarsal vessels are obscured.

TI reflects more severe active inflammatory disease.

TS – Trachomatous Scarring

The tarsal conjunctiva develops visible:

• White bands
• Fibrous lines
• Sheets of scar tissue

A classic horizontal scar is:

Arlt line.

Scarring indicates prior repeated inflammation rather than active infection itself.

TT – Trachomatous Trichiasis

Defined clinically by:

At least one eyelash touching the globe or evidence of recent removal of in-turned lashes.

This is the key sight-threatening stage because lashes repeatedly abrade the cornea.

CO – Corneal Opacity

There is corneal scarring severe enough to:

Obscure part of the pupil margin.

This represents advanced disease and is the major cause of irreversible visual loss.

Classic Conjunctival Findings

Active disease most characteristically affects the:

Upper tarsal conjunctiva.

Findings may include:

• Follicles
• Papillary hypertrophy
• Conjunctival thickening
• Hyperemia

Repeated episodes eventually produce:

• Fibrosis
• Foreshortening
• Lid distortion

Herbert Pits

Herbert pits are small depressions at the superior limbus produced by healed limbal follicles.

They are:

• Evidence of previous trachomatous inflammation
• Characteristic of established disease

but are not required for diagnosis.

Corneal Pannus

Active or chronic trachoma may produce:

Superficial corneal vascularization and infiltration, particularly from the superior limbus.

This is termed:

Trachomatous pannus.

Advanced pannus and repeated lash trauma may contribute to corneal scarring.

Arlt Line

An Arlt line is a horizontal band of scar tissue across the upper tarsal conjunctiva.

It is a classic sign of:

Chronic cicatricial trachoma.

How Patients Present During Active Disease

Children may be:

Asymptomatic

or have:

• Mild redness
• Tearing
• Mucous discharge
• Irritation
• Itching
• Foreign-body sensation

The relatively mild symptoms help explain why infection can circulate extensively within communities.

How Adults With Late Disease Present

Patients with trichiasis may report:

• Foreign-body sensation
• Tearing
• Photophobia
• Ocular pain
• Reduced vision

Symptoms frequently reflect:

Mechanical lash-cornea contact rather than ongoing Chlamydia infection.

How the Diagnosis Is Usually Made

In endemic settings, trachoma is primarily a:

Clinical diagnosis

using the characteristic upper tarsal conjunctival and eyelid findings.

Laboratory testing is generally unnecessary for routine individual diagnosis.

Role of PCR

Nucleic-acid amplification testing can detect:

C. trachomatis DNA

from conjunctival specimens.

PCR is most useful for:

• Research
• Surveillance
• Programmatic assessment
• Unusual diagnostic situations

Clinical signs and active infection do not always correlate perfectly because inflammation may persist after organisms have disappeared.

Why Older Cytology Tests Are Less Important

Historical testing included:

• Giemsa staining for inclusions
• Direct fluorescent antibody testing
• Enzyme immunoassay

These have largely been replaced by:

Nucleic-acid amplification methods

when laboratory confirmation is required.

Important Diagnostic Alternatives in Active Disease

Consider:

• Adenoviral conjunctivitis
• Adult inclusion conjunctivitis
• Bacterial conjunctivitis
• Toxic medicamentosa
• Molluscum-associated conjunctivitis
• Allergic follicular conjunctivitis

Trachoma vs Adult Inclusion Conjunctivitis

This distinction is important.

Trachoma

Caused by:

C. trachomatis A, B, Ba, C

and associated with endemic community transmission and chronic scarring.

Adult Inclusion Conjunctivitis

Usually caused by:

C. trachomatis D–K

and is typically sexually acquired.

Adult inclusion conjunctivitis generally does not produce the classic community-level blinding cicatricial disease of endemic trachoma.

Cicatricial Disease Differential

Other causes of conjunctival scarring and trichiasis include:

• Mucous membrane pemphigoid
• Stevens–Johnson syndrome
• Toxic epidermal necrolysis
• Chemical injury
• Severe chronic blepharoconjunctivitis
• Prior ocular surgery or trauma

The epidemiologic history and classic tarsal pattern are important.

The SAFE Strategy

The cornerstone of global trachoma control remains the WHO:

SAFE strategy

which stands for:

S – Surgery for trichiasis

A – Antibiotics to reduce ocular C. trachomatis infection

F – Facial cleanliness

E – Environmental improvement

Each component addresses a different stage of the disease.

S – Surgery for Trachomatous Trichiasis

Patients with lashes touching the globe require:

Prompt eyelid treatment

because continued lash trauma can permanently scar the cornea.

Common procedures include:

• Bilamellar tarsal rotation
• Posterior lamellar tarsal rotation

The surgical goal is to rotate the eyelid margin outward and prevent lashes from contacting the cornea.

Why Epilation Is Not Definitive Treatment

Temporary epilation can reduce corneal trauma when surgery is not immediately available.

However:

Repeated lash plucking does not correct the underlying entropion.

Definitive lid surgery is preferred for significant trachomatous trichiasis.

A – Antibiotic Treatment

The preferred antibiotic for active trachoma and population control is usually:

Oral azithromycin

A commonly used single-dose regimen is:

• Adults: 1 g orally once
• Children: 20 mg/kg orally once, up to the adult maximum

Exact programmatic dosing follows local or WHO protocols.

Alternative Antibiotic Therapy

When azithromycin cannot be used, an established alternative is:

Topical tetracycline 1% ophthalmic ointment twice daily for 6 weeks.

This prolonged topical course is less convenient, which is why azithromycin is generally favored.

Important Modern Correction About Doxycycline

Older sources sometimes listed short oral doxycycline courses as routine trachoma therapy.

For endemic trachoma control:

Single-dose azithromycin or topical tetracycline remains the standard programmatic approach.

Doxycycline is not the usual first-line population treatment.

Why Community Treatment Is Necessary

Treating one symptomatic child is often insufficient because infection circulates throughout:

• Families
• Households
• Villages

In endemic districts, antibiotic programs may therefore involve:

Mass drug administration (MDA).

How Mass Azithromycin Programs Work

Communities above programmatic prevalence thresholds may receive:

Annual mass azithromycin treatment

for multiple years.

Repeat surveys determine whether:

• Additional rounds are required
• Transmission has fallen sufficiently

The exact schedule depends on local prevalence and elimination-program criteria rather than a fixed universal number of treatments.

F – Facial Cleanliness

Regular cleaning of children’s faces reduces:

• Ocular discharge
• Nasal secretions
• Fly attraction
• Opportunity for person-to-person transmission

Children with persistently dirty faces are more likely to sustain community transmission.

E – Environmental Improvement

Important measures include:

• Access to clean water
• Household latrines
• Proper disposal of feces
• Reduced household crowding
• Improved sanitation
• Fly control where relevant

Antibiotics alone cannot provide durable elimination when transmission conditions persist.

When Trachoma Is Considered Eliminated as a Public Health Problem

Modern elimination programs assess population-level indicators including very low prevalence of:

• Trachomatous inflammation–follicular in young children
• Trachomatous trichiasis in adults that remains unknown to the health system

Countries must also demonstrate the capacity to identify and manage new trichiasis cases.

Elimination does not mean the organism has disappeared completely; it means the blinding public-health burden has fallen below defined thresholds.

Managing Corneal Surface Disease

Patients with trichiasis-related epithelial injury may require:

• Lubricating drops
• Ointment
• Treatment of secondary bacterial infection when present

However, lubrication does not replace:

Correction of the lid abnormality.

Corneal Transplantation

Advanced central corneal opacity may occasionally require:

• Penetrating keratoplasty
• Selected other corneal rehabilitation

However, prognosis may be limited by:

• Severe ocular-surface disease
• Corneal vascularization
• Dry eye
• Persistent lid abnormality

Any trichiasis or entropion should be corrected:

Before considering corneal transplantation.

Dry Eye in Cicatricial Trachoma

Chronic conjunctival scarring can destroy:

• Goblet cells
• Accessory lacrimal structures

leading to:

Chronic ocular-surface dryness.

This may further contribute to epithelial instability and corneal damage.

Why Women Often Carry More Late Disease

Women in endemic communities often have greater cumulative exposure to infected young children.

Consequently, they may experience:

• More repeated infections
• More conjunctival scarring
• Greater risk of trichiasis

The increased late burden is therefore largely related to:

Exposure patterns rather than an intrinsic sex-specific ocular susceptibility.

Preventing Progression to Blindness

The most important interventions are:

• Reduce childhood transmission
• Treat endemic infection at community level
• Identify trichiasis early
• Operate before irreversible central corneal scarring develops

Once dense central corneal opacity occurs, antibiotic treatment cannot restore transparency.

Follow-Up After Trichiasis Surgery

Patients require follow-up for:

• Recurrent trichiasis
• Eyelid contour abnormality
• Corneal healing
• Persistent entropion
• Overcorrection

Recurrence can occur even after technically successful surgery.

Expected Clinical Course

Repeated infection in childhood may produce progressively more conjunctival fibrosis.

The cicatricial consequences may not become clinically important until:

Years or decades later.

Thus adults with trichiasis may no longer have active Chlamydia infection.

Major Causes of Vision Loss

Visual impairment primarily results from:

• Trichiasis-induced corneal abrasion
• Recurrent microbial keratitis
• Corneal vascularization
• Chronic ocular-surface disease
• Dense corneal scarring

The optic nerve and retina are not the principal targets.

High-Yield Takeaways

• Trachoma is a chronic keratoconjunctivitis caused by Chlamydia trachomatis serovars A, B, Ba, and C.
• Blindness results not from a single infection but from recurrent childhood infection causing progressive conjunctival scarring, entropion, trichiasis, and corneal opacity.
• Active disease predominantly affects young children, while cicatricial trichiasis and blindness appear mainly in adults.
• Transmission occurs primarily through hands, ocular/nasal secretions, fomites, and eye-seeking flies; coughing and sneezing are not major routes.
• The WHO simplified grading system is TF, TI, TS, TT, CO.
• TF = ≥5 follicles ≥0.5 mm on the central upper tarsal conjunctiva.
• TI = intense tarsal inflammation obscuring more than half of deep conjunctival vessels.
• TS = visible tarsal conjunctival scarring.
• TT = at least one lash touching the globe or evidence of recent epilation.
• CO = corneal opacity involving the pupil margin.
• Classic late signs include Arlt lines, Herbert pits, entropion, trichiasis, and superior corneal pannus.
• Laboratory confirmation is usually unnecessary clinically; PCR is mainly used for surveillance, research, or selected uncertain cases.
• The global control strategy remains SAFE: Surgery, Antibiotics, Facial cleanliness, Environmental improvement.
• Single-dose oral azithromycin is the preferred antibiotic for active disease and mass treatment programs; topical tetracycline 1% twice daily for 6 weeks is an alternative.
• Community antibiotic administration is guided by local prevalence, not simply by treatment of symptomatic individuals.
• Trichiasis surgery is the key sight-saving intervention once cicatricial lid disease develops.
• Epilation may provide temporary relief but does not correct the underlying entropion.
• Corneal transplantation has a guarded prognosis when there is severe vascularization or ocular-surface scarring and should only be considered after eyelid abnormalities are corrected.
• Sustained elimination depends on both antibiotics and improvements in water access, facial hygiene, sanitation, and environmental conditions.
• Trachoma is increasingly being eliminated as a public-health problem in many countries, but it remains a preventable cause of blindness in several endemic regions.

Ophthalmology – Ocular Toxocariasis

What the Disorder Represents

Ocular toxocariasis is an ocular larva migrans syndrome caused by infection with Toxocara species, most commonly:

• Toxocara canis
• Toxocara cati

It usually results from migration of a single or small number of larvae into the eye, producing:

• Granulomatous inflammation
• Vitritis
• Retinal or choroidal granuloma
• Tractional vitreoretinal changes

Disease is classically:

Unilateral

and most often occurs in:

• Children
• Adolescents

but adults can also be affected.

How Infection Is Acquired

Humans acquire infection by ingesting embryonated Toxocara eggs from:

• Soil contaminated with dog or cat feces
• Contaminated hands
• Unwashed produce
• Other contaminated environments

Less commonly, infection may follow ingestion of larvae in:

• Raw or undercooked animal tissues

Humans are:

Paratenic hosts

rather than normal definitive hosts.

What Happens After the Eggs Are Ingested

Larvae hatch in the intestine and migrate through the bloodstream.

They may reach:

• Liver
• Lungs
• CNS
• Eye

Within ocular tissues, the larva induces:

Marked eosinophilic and granulomatous inflammation.

The ocular disease often occurs with:

Minimal or absent systemic symptoms.

Relationship to Visceral Larva Migrans

Systemic toxocariasis may produce:

• Fever
• Hepatomegaly
• Cough
• Wheeze
• Eosinophilia
• Elevated immunoglobulins

This syndrome is often called:

Visceral larva migrans.

Ocular toxocariasis, however, usually occurs in:

• Older children
• Adolescents
• Adults

and may have:

No eosinophilia and no significant systemic illness.

Why Ocular Disease Is Often Unilateral

The ocular phenotype often results from migration of only:

One or a few larvae

to one eye.

Therefore bilateral ocular toxocariasis is:

Uncommon.

The Three Classic Ocular Presentations

The traditional patterns are:

1. Posterior pole granuloma
2. Peripheral granuloma
3. Diffuse endophthalmitis-like inflammation

These are clinical phenotypes rather than completely separate diseases.

Posterior Pole Granuloma

A posterior granuloma typically appears as:

• White or yellow-white elevated lesion
• Usually at the posterior pole
• Often near the macula or optic disc

It may be associated with:

• Vitritis
• Retinal folds
• Epiretinal membrane
• Macular distortion

Posterior lesions are often diagnosed in somewhat older children or adults.

Peripheral Granuloma

A peripheral granuloma usually appears as:

• White elevated peripheral retinal mass
• Often associated with vitreoretinal traction

Complications include:

• Retinal dragging
• Falciform retinal fold
• Macular ectopia
• Tractional retinal detachment

This form may be mistaken for other pediatric retinal disorders.

Endophthalmitis-Like Presentation

The diffuse inflammatory form may produce:

• Dense vitritis
• Granulomatous anterior uveitis
• Hypopyon
• Leukocoria
• Poor fundus view

A peripheral or posterior granuloma may be hidden behind the inflammatory haze.

This presentation is especially important because it can mimic:

Retinoblastoma.

Optic Nerve Involvement

Less commonly, Toxocara can cause:

• Optic disc edema
• Neuroretinitis-like disease
• Peripapillary granuloma
• Optic nerve inflammation

This may lead to:

• Reduced vision
• Disc hyperemia
• Peripapillary exudation

What Patients Usually Notice

Symptoms may include:

• Reduced vision
• Floaters
• Strabismus
• Leukocoria
• Unilateral visual blur

Pain and severe photophobia are often less prominent than in many other forms of uveitis.

Young children may present only because a parent notices:

• Eye deviation
• White pupillary reflex
• Poor visual behavior

Strabismus and Amblyopia

Because disease commonly occurs in childhood, even moderate unilateral visual impairment can produce:

Amblyopia.

Strabismus may be:

• A presenting feature
• Secondary to visual loss

Therefore visual rehabilitation is an important part of management.

Anterior Segment Findings

Possible anterior findings include:

• Granulomatous keratic precipitates
• Anterior chamber cells
• Posterior synechiae
• Hypopyon in severe cases

However, many patients have primarily:

Posterior segment disease.

Vitreous Findings

Vitritis may range from:

• Mild cells and haze
• Dense inflammatory vitreous opacity

Vitreous inflammation often accompanies:

• Active granuloma
• Tractional disease

Retinal and Choroidal Findings

Possible posterior findings include:

• White granuloma
• Retinal traction
• Epiretinal membrane
• Retinal folds
• Exudation
• Retinal detachment
• Macular ectopia

Chronic traction may be a major cause of visual loss.

How the Diagnosis Is Made

Diagnosis is based on a combination of:

1. Compatible clinical appearance
2. Exposure history
3. Ocular imaging
4. Serologic or ocular-fluid antibody testing when useful
5. Exclusion of major mimics

There is no single test that proves every case.

Exposure History

Ask about:

• Dogs or cats
• Puppies or kittens
• Soil exposure
• Geophagia/pica
• Outdoor play
• Agricultural exposure
• Poor hand hygiene
• Raw or undercooked animal tissue

However:

Absence of a clear exposure history does not exclude toxocariasis.

Serum Toxocara Antibody Testing

Serum Toxocara IgG ELISA may support the diagnosis.

Important limitation:

Serum antibody sensitivity is lower in isolated ocular toxocariasis than in systemic disease.

A negative serum test therefore does:

Not completely exclude ocular infection.

Why Serum Serology Can Be Misleading

Positive serum antibodies may reflect:

• Prior exposure
• Past infection
• Current infection

rather than proving that the ocular lesion is caused by Toxocara.

Interpretation must be based on:

Clinical correlation.

Ocular Fluid Antibody Testing

When diagnosis remains uncertain, testing:

• Aqueous humor
• Vitreous

for Toxocara-specific antibodies can provide stronger support.

Comparison of intraocular to serum antibody levels using a:

Goldmann-Witmer coefficient

may help demonstrate local antibody production.

Role of Eosinophilia

Peripheral eosinophilia is common in:

Visceral larva migrans

but is often:

Absent in isolated ocular toxocariasis.

Therefore a normal eosinophil count does not rule out ocular disease.

Optical Coherence Tomography

OCT is valuable for detecting:

• Vitreoretinal traction
• Epiretinal membrane
• Macular distortion
• Intraretinal or subretinal fluid
• Structural relationship of posterior granuloma to the retina

It is particularly useful for surgical planning.

B-Scan Ultrasonography

Ultrasound is important when:

• Vitritis obscures the fundus
• Leukocoria is present
• Retinoblastoma is in the differential

Possible findings include:

• Vitreous membranes
• Tractional retinal detachment
• Peripheral mass-like lesion

A crucial distinction is that Toxocara granulomas generally:

Do not contain the dense calcification typical of retinoblastoma.

Why Retinoblastoma Must Be Excluded

In a child with:

• Leukocoria
• Vitritis
• Retinal mass
• Retinal detachment

the most important diagnosis to exclude is:

Retinoblastoma.

Mistaking retinoblastoma for inflammatory disease can be catastrophic.

Important Differential Diagnoses

Consider:

• Retinoblastoma
• Coats disease
• Persistent fetal vasculature
• Familial exudative vitreoretinopathy
• Retinopathy of prematurity
• Toxoplasmosis
• Sarcoidosis
• Endogenous endophthalmitis
• Other posterior uveitides

Distinguishing It From Retinoblastoma

Ocular Toxocariasis

• Usually unilateral
• Granuloma
• Vitritis common
• Tractional folds
• No true intratumoral calcification

Retinoblastoma

• Intraocular tumor
• Calcification common
• Subretinal/vitreous seeds may occur
• Leukocoria common

Imaging and specialist examination are essential when the distinction is uncertain.

Distinguishing It From Coats Disease

Coats disease typically shows:

• Retinal telangiectasia
• Lipid exudation
• Exudative retinal detachment

without the characteristic:

• Granuloma
• Marked vitritis

seen in toxocariasis.

Distinguishing It From Toxoplasmosis

Ocular toxoplasmosis more typically produces:

• Necrotizing retinitis
• Dense overlying vitritis
• Pigmented scar in recurrent disease

Toxocariasis more commonly produces:

Granuloma and vitreoretinal traction.

Main Treatment Goal

Management has two objectives:

1. Suppress damaging ocular inflammation
2. Treat the parasite when clinically appropriate

Treatment is individualized according to:

• Activity
• Location
• Visual threat
• Degree of traction
• Diagnostic certainty

Corticosteroids

When active inflammation threatens vision, corticosteroids are commonly used.

Options include:

• Topical corticosteroids for significant anterior inflammation
• Periocular corticosteroid in selected cases
• Systemic corticosteroids for severe posterior inflammation

The goal is to reduce:

• Vitritis
• Macular involvement
• Inflammatory tissue damage

Cycloplegic Therapy

Cycloplegics may be useful when there is significant anterior uveitis to:

• Reduce pain from ciliary spasm
• Prevent or break posterior synechiae

Anthelmintic Therapy – Modern Perspective

Older teaching often stated that antiparasitic treatment was rarely used in ocular disease.

Current practice is more nuanced.

Albendazole is often considered in active ocular toxocariasis, particularly when there is evidence of ongoing larval activity.

It is usually given:

Together with corticosteroid therapy

when significant ocular inflammation is present.

Why Steroids May Accompany Albendazole

Killing the larva can theoretically increase inflammatory antigen release.

Therefore corticosteroids may help reduce:

Treatment-associated inflammatory worsening.

The exact regimen varies among specialists.

Common Anthelmintic Options

Albendazole is generally preferred.

Mebendazole is used less commonly.

Treatment duration varies depending on:

• Disease activity
• Systemic involvement
• Specialist protocol

There is no single universally standardized ocular regimen.

When Anthelmintic Therapy May Be Less Useful

A chronic inactive granuloma with:

• No active inflammation
• Established fibrosis
• Long-standing traction

may represent the sequela of prior infection rather than ongoing active larval migration.

In such cases, antihelminthic therapy may provide limited benefit.

Surgical Management

Pars plana vitrectomy may be needed for:

• Tractional retinal detachment
• Dense persistent vitreous opacity
• Severe vitreoretinal traction
• Epiretinal membrane
• Diagnostic uncertainty requiring vitreous sampling

Goals of Vitrectomy

Surgery may:

• Clear the visual axis
• Release vitreoretinal traction
• Reattach the retina
• Improve macular position
• Obtain diagnostic material

Visual recovery depends heavily on the pre-existing degree of retinal and macular damage.

Retinal Fold and Macular Ectopia

Chronic peripheral traction can pull the retina toward the granuloma, creating:

• Falciform folds
• Macular displacement

Surgical release may be possible in selected cases, but longstanding distortion can limit visual recovery.

Laser Treatment

Laser photocoagulation directed at an identifiable larva has been reported historically.

It is:

Rarely used in modern practice

because the larva is usually not directly visible and pharmacologic/inflammatory management is more practical.

Amblyopia Management

Children require assessment for:

• Refractive error
• Anisometropia
• Strabismic amblyopia
• Deprivation amblyopia

Treatment may include:

• Optical correction
• Patching
• Other amblyopia therapy

This should begin as early as the ocular condition permits.

Monocular Protection

Patients with severe permanent unilateral visual loss should use:

Protective polycarbonate eyewear

to reduce the risk of injury to the better-seeing eye.

Follow-Up Strategy

Follow-up depends on:

• Degree of inflammation
• Macular involvement
• Retinal traction
• Treatment

Active disease may require relatively frequent review.

Stable chronic granulomas can be monitored less often.

Prevention

Preventive measures include:

• Handwashing after handling soil or pets
• Prompt disposal of dog and cat feces
• Preventing children from eating soil
• Routine veterinary deworming
• Covering sandboxes
• Washing produce

These measures reduce environmental transmission.

Pet Ownership Does Not Automatically Mean High Risk

The key risk is not simply owning a dog or cat.

Transmission depends on:

• Exposure to contaminated feces
• Environmental egg maturation
• Hygiene practices

Proper veterinary care substantially reduces risk.

Expected Visual Outcome

Prognosis depends mainly on:

• Granuloma location
• Macular involvement
• Degree of vitritis
• Retinal traction
• Amblyopia
• Retinal detachment

Patients with small peripheral lesions may retain:

Excellent central vision.

Features Associated With Worse Vision

Poorer prognosis is associated with:

• Macular granuloma
• Optic nerve involvement
• Dense chronic vitritis
• Tractional retinal detachment
• Macular ectopia
• Severe amblyopia

Long-Term Complications

Potential complications include:

• Permanent visual loss
• Epiretinal membrane
• Vitreoretinal traction
• Macular ectopia
• Tractional retinal detachment
• Cataract
• Secondary glaucoma
• Phthisis bulbi in severe neglected disease

Enucleation is now rarely required and should mainly arise when another serious diagnosis, particularly retinoblastoma, has been excluded and the eye is severely painful or nonfunctional.

High-Yield Takeaways

• Ocular toxocariasis is a usually unilateral granulomatous posterior uveitis caused by Toxocara canis or Toxocara cati larvae.
• The three classic presentations are posterior granuloma, peripheral granuloma, and diffuse endophthalmitis-like inflammation.
• Children are affected most often, but adults can also develop disease.
• Exposure occurs through ingestion of embryonated eggs from fecally contaminated soil or environments, not simply from touching a dog or cat.
• Isolated ocular toxocariasis often occurs without eosinophilia or systemic symptoms.
• Serum Toxocara IgG can support the diagnosis, but negative serum serology does not exclude isolated ocular disease.
• Aqueous or vitreous antibody testing, particularly evidence of local antibody production, can strengthen difficult diagnoses.
• OCT is especially useful for detecting vitreoretinal traction and macular distortion.
• B-scan ultrasonography is important when leukocoria or dense vitritis prevents fundus visualization.
• In a child with leukocoria and an intraocular mass, retinoblastoma must be excluded before assuming toxocariasis.
• Unlike retinoblastoma, a Toxocara granuloma usually lacks true calcification.
• Corticosteroids are used to control vision-threatening inflammation.
• Modern management may include albendazole, often combined with corticosteroids, in active ocular disease; antihelminthic therapy is not simply “never used.”
• Chronic inactive fibrotic granulomas may respond poorly to antiparasitic therapy because the major problem is established structural damage.
• Vitrectomy may be required for tractional retinal detachment, dense persistent vitritis, epiretinal membrane, or severe vitreoretinal traction.
• Children must be assessed and treated for amblyopia and strabismus.
• Long-term visual outcome depends mainly on macular involvement, traction, retinal detachment, and amblyopia.

Ophthalmology – Toxic and Nutritional Optic Neuropathy

What the Disorder Represents

Toxic and nutritional optic neuropathies are acquired disorders of the optic nerve caused by:

• Medications
• Environmental or industrial toxins
• Toxic alcohols
• Nutritional deficiencies
• Combinations of toxic exposure and malnutrition

The classic presentation is:

Painless, bilateral, symmetric, progressive central visual loss with dyschromatopsia and central or cecocentral scotomas.

The preferentially damaged fibers are those of the:

Papillomacular bundle.

The Classic Clinical Pattern

Think of toxic or nutritional optic neuropathy when there is:

• Bilateral symmetric visual loss
• Reduced color vision
• Loss of contrast sensitivity
• Central or cecocentral visual-field defects
• Initially normal or mildly swollen optic discs
• Later temporal or diffuse optic atrophy

Most cases evolve:

Subacutely over weeks to months.

Acute catastrophic visual loss is more characteristic of certain poisonings, especially:

Methanol.

Why the Papillomacular Bundle Is Vulnerable

Many toxic and nutritional optic neuropathies interfere with:

Mitochondrial oxidative phosphorylation

and cellular energy production.

Small-caliber fibers of the papillomacular bundle have particularly high metabolic demand and limited energetic reserve.

The resulting sequence is:

Mitochondrial dysfunction → axonal injury → retinal ganglion cell loss → temporal optic atrophy.

Common Toxic Causes

Important toxic or medication-associated causes include:

• Ethambutol
• Linezolid
• Methanol
• Amiodarone
• Disulfiram
• Tacrolimus
• Cyclosporine
• Chloramphenicol, rarely
• Certain chemotherapeutic agents

Not every association has the same strength of evidence.

Common Nutritional Causes

Important deficiencies include:

• Vitamin B12
• Folate
• Copper
• Thiamine

Multiple deficiencies may coexist, especially in patients with:

• Severe malnutrition
• Bariatric surgery
• Gastrointestinal disease
• Chronic alcohol misuse
• Restricted diets
• Malabsorption syndromes

The “Tobacco-Alcohol Amblyopia” Concept

The older term:

Tobacco-alcohol amblyopia

is now considered misleading.

Alcohol itself is not usually viewed as a direct optic nerve toxin in this setting.

Instead, affected patients often have:

• Nutritional deficiency
• Poor dietary intake
• Smoking-related toxic exposure
• Multiple metabolic stressors

A better concept is:

Nutritional optic neuropathy with possible toxic contribution.

Smoking and Optic Neuropathy

Heavy tobacco exposure has historically been associated with toxic-nutritional optic neuropathy, potentially through:

• Cyanide exposure
• Oxidative stress
• Nutritional deficiency

However, isolated smoking is not usually sufficient to establish the diagnosis without supporting clinical context.

Ethambutol – The Classic Drug Cause

Ethambutol-associated optic neuropathy is one of the most important preventable causes.

It typically produces:

• Bilateral painless visual loss
• Red-green dyschromatopsia
• Central or cecocentral scotomas
• Reduced contrast sensitivity

The optic discs may initially appear:

Normal.

How Ethambutol Injures the Optic Nerve

Ethambutol is thought to interfere with mitochondrial function, possibly through:

• Metal chelation
• Disruption of mitochondrial enzymes
• Oxidative stress

The papillomacular bundle is preferentially affected.

Major Risk Factors for Ethambutol Toxicity

Risk increases with:

• Higher daily dose
• Longer duration
• Renal impairment
• Older age
• Reduced body mass
• Pre-existing optic nerve disease

Because ethambutol is renally cleared, impaired kidney function can substantially increase exposure.

Why Weight-Based Dosing Matters

Ethambutol toxicity is strongly related to:

Dose per kilogram of body weight.

Standard tuberculosis regimens use carefully weight-adjusted dosing.

Risk rises at higher doses and with prolonged treatment, especially when renal clearance is impaired.

When Ethambutol Toxicity Can Appear

Most cases develop after:

Several months of treatment

but toxicity can occur earlier, particularly with:

• High dose
• Renal dysfunction
• Individual susceptibility

Late toxicity after prolonged treatment is also possible.

Baseline Assessment Before Ethambutol

Patients expected to receive prolonged ethambutol therapy should ideally have baseline documentation of:

• Visual acuity
• Color vision
• Relevant ocular history

Formal ophthalmic assessment is particularly valuable in patients with:

• Renal disease
• Pre-existing eye disease
• Difficulty reporting symptoms
• Higher anticipated dose or prolonged therapy

Monitoring During Ethambutol Therapy

Patients should be educated to report immediately:

• Blurred central vision
• Reduced ability to read
• New central spot
• Loss or fading of red/green color

Monitoring should become more intensive in:

• High-risk patients
• Prolonged courses
• Renal dysfunction
• Higher dosing

What to Do When Ethambutol Toxicity Is Suspected

The key intervention is:

Stop ethambutol promptly in coordination with the treating infectious-disease or tuberculosis team.

An alternative antituberculous regimen may be required.

Do not continue the medication while waiting for severe optic disc changes to develop.

Can Ethambutol Vision Recover?

Recovery is:

Variable.

Some patients improve significantly after stopping the drug, especially when toxicity is recognized early.

However:

• Recovery may take months
• Some patients continue worsening temporarily after cessation
• Permanent central visual loss can occur

Therefore prevention and early detection are critical.

Linezolid Optic Neuropathy

Prolonged linezolid therapy may cause:

• Bilateral visual loss
• Dyschromatopsia
• Central scotoma
• Optic neuropathy

It may coexist with:

Peripheral neuropathy.

Risk increases particularly with treatment extending beyond the usual short-course duration.

Methanol – The Ophthalmic Emergency

Methanol poisoning can cause profound bilateral visual loss and death.

Methanol is metabolized to:

Formic acid

which inhibits mitochondrial cytochrome oxidase and produces:

• Severe metabolic acidosis
• Retinal and optic nerve toxicity
• CNS injury

Common Methanol Exposure Settings

Methanol poisoning may follow:

• Contaminated or illicit alcohol
• Windshield washer fluid
• Industrial solvents
• Accidental ingestion

Outbreaks may occur after consumption of:

Adulterated alcoholic beverages.

Symptoms of Methanol Poisoning

After a latent period, patients may develop:

• Headache
• Nausea
• Vomiting
• Abdominal discomfort
• Confusion
• Dyspnea

Visual symptoms include:

• Blurred vision
• Photophobia
• Central scotoma
• “Snowfield” or foggy vision
• Severe bilateral visual loss

Ocular Findings in Methanol Toxicity

Possible findings include:

• Hyperemic or edematous optic discs
• Peripapillary retinal edema
• Reduced pupillary responses
• Severe visual loss

Later there may be:

Optic atrophy.

Methanol Is a Medical Emergency

Suspected methanol poisoning requires:

Immediate emergency toxicology management.

Do not wait for a confirmed serum methanol level when the history and metabolic picture are strongly suggestive.

Emergency Treatment of Methanol Poisoning

Treatment may include:

• Fomepizole
• Sodium bicarbonate for significant acidosis
• Hemodialysis in severe cases
• Folinic acid or folic acid to enhance formate metabolism
• Intensive supportive care

Ethanol can be used as an antidote when fomepizole is unavailable, but fomepizole is generally preferred because dosing and monitoring are easier.

When Hemodialysis Is Needed

Hemodialysis is strongly considered with features such as:

• Severe metabolic acidosis
• Visual symptoms
• End-organ toxicity
• High methanol concentration
• Clinical deterioration

Dialysis removes:

• Methanol
• Formate

and helps correct severe metabolic abnormalities.

Important Correction About Ethylene Glycol

Ethylene glycol poisoning is also life-threatening, but its classic toxicity is different.

It primarily causes:

• High-anion-gap metabolic acidosis
• Renal failure
• Hypocalcemia
• Calcium oxalate deposition

Severe optic neuropathy is much more characteristic of:

Methanol

than ethylene glycol.

Ethylene glycol can produce neurologic complications, including delayed cranial neuropathies, but should not be treated as a classic equivalent cause of toxic optic neuropathy.

Carbon Monoxide and Cyanide

Severe exposure to:

• Carbon monoxide
• Cyanide

can cause neurologic and visual dysfunction through:

Cellular hypoxia and mitochondrial toxicity.

Visual deficits may arise from:

• Optic nerve injury
• Retinal injury
• Occipital cerebral injury

rather than a pure papillomacular toxic optic neuropathy in every case.

Amiodarone and Optic Neuropathy

Amiodarone has been associated with an optic neuropathy characterized by:

• Insidious visual decline
• Disc edema that may be prolonged
• Often bilateral involvement

However, causality can be difficult to establish because many patients taking amiodarone also have vascular risk factors for:

NAION.

PDE-5 Inhibitors – Important Modern Perspective

Older literature sometimes grouped phosphodiesterase-5 inhibitors such as sildenafil with toxic optic neuropathy.

This is not the preferred modern classification.

PDE-5 inhibitors have been reported in association with:

Nonarteritic anterior ischemic optic neuropathy (NAION)

but a direct causal relationship remains debated.

This is therefore not the typical bilateral papillomacular toxic neuropathy described in this chapter.

Nutritional Optic Neuropathy

Nutritional optic neuropathy usually develops gradually and produces:

• Bilateral central visual loss
• Dyschromatopsia
• Cecocentral scotomas
• Temporal optic disc pallor

Multiple nutritional deficiencies may coexist.

Vitamin B12 Deficiency

Vitamin B12 deficiency may result from:

• Pernicious anemia
• Vegan or highly restrictive diet without supplementation
• Gastric surgery
• Ileal disease
• Malabsorption

Neurologic manifestations may include:

• Peripheral neuropathy
• Sensory ataxia
• Myelopathy
• Cognitive change

Optic neuropathy is uncommon but well recognized.

Laboratory Clues to B12 Deficiency

Useful tests include:

• Serum vitamin B12
• Methylmalonic acid
• Homocysteine
• CBC with indices

A borderline serum B12 level may still represent functional deficiency, particularly when:

Methylmalonic acid is elevated.

Folate Deficiency

Folate deficiency can produce a similar optic neuropathy.

Potential causes include:

• Poor diet
• Alcohol-associated malnutrition
• Malabsorption
• Certain medications

Folate should generally not be replaced blindly without considering concurrent:

Vitamin B12 deficiency

because hematologic improvement can mask ongoing neurologic B12 injury.

Copper Deficiency

Copper deficiency is an important and often overlooked cause.

Risk factors include:

• Bariatric surgery
• Malabsorption
• Excess zinc supplementation
• Long-term enteral or parenteral nutrition abnormalities

It may produce:

• Optic neuropathy
• Myelopathy
• Peripheral neuropathy
• Anemia or neutropenia

Thiamine Deficiency

Thiamine deficiency is best known for:

Wernicke encephalopathy

but may rarely be associated with optic neuropathy.

Look for:

• Malnutrition
• Alcohol use disorder
• Bariatric surgery
• Hyperemesis
• Prolonged inadequate nutrition

Because neurologic injury can be serious, treatment should not be delayed when deficiency is strongly suspected.

History Is Often the Key Test

A detailed history should cover:

• All prescription drugs
• Recent medication changes
• Duration and dose
• Occupational exposure
• Alcohol intake
• Smoking
• Diet
• Weight loss
• Bariatric surgery
• Gastrointestinal disease
• Supplements
• Possible toxic alcohol ingestion

Exposure history is often more diagnostically useful than any single blood test.

What the Eye Examination Usually Shows

Typical findings include:

• Reduced visual acuity
• Reduced color vision
• Reduced contrast sensitivity
• Relative preservation of peripheral fields
• Initially normal optic discs

Later:

• Temporal pallor
• Diffuse optic atrophy

may develop.

Why the Optic Disc May Initially Look Normal

Toxic and nutritional injury often begins:

Retrobulbar or within the papillomacular fibers

before enough axons are lost to produce visible disc pallor.

Therefore a normal-looking disc does not exclude significant disease.

OCT Findings

OCT may show:

• Early macular ganglion cell complex thinning
• Later temporal RNFL thinning
• Diffuse RNFL loss in advanced disease

Ganglion cell loss may sometimes precede obvious optic disc pallor.

Visual Field Pattern

The classic defect is:

Central or cecocentral scotoma

which reflects injury to the papillomacular bundle.

Peripheral fields are often relatively preserved until disease becomes advanced.

Color Vision

Color testing frequently shows:

• Reduced saturation
• Red-green or generalized dyschromatopsia

Color loss may be:

Disproportionate to Snellen visual acuity reduction.

Neuroimaging

MRI of the brain and orbits with contrast is useful when:

• Diagnosis is uncertain
• Loss is asymmetric
• Progression is atypical
• Neurologic signs are present

The main purpose is usually to exclude:

• Compressive optic neuropathy
• Inflammatory optic neuritis
• Chiasmal disease
• Infiltrative disease

MRI may be normal in classic toxic-nutritional optic neuropathy.

Laboratory Evaluation

Depending on the clinical situation, consider:

• CBC
• Vitamin B12
• Methylmalonic acid
• Folate
• Copper
• Thiamine
• Comprehensive metabolic panel
• Renal function

Additional testing should be guided by:

• Diet
• Drug exposure
• Systemic symptoms

Toxic Alcohol Workup

When methanol or ethylene glycol poisoning is suspected, urgent studies may include:

• Blood gas
• Electrolytes
• Anion gap
• Osmolal gap
• Renal function
• Serum toxic alcohol levels when available

Treatment should not necessarily wait for confirmatory levels in a seriously ill patient.

Important Diagnostic Alternatives

The differential diagnosis includes:

• Leber hereditary optic neuropathy
• Dominant optic atrophy
• Optic neuritis
• Compressive optic neuropathy
• Maculopathy
• Cone dystrophy
• Chiasmal disease

Distinguishing It From Leber Hereditary Optic Neuropathy

LHON often produces:

• Young adult onset
• Sequential involvement of the two eyes
• Central scotoma
• Dyschromatopsia
• Characteristic mitochondrial inheritance

Early fundus findings may include:

• Peripapillary telangiectatic vessels
• RNFL swelling

Genetic testing helps confirm the diagnosis.

Distinguishing It From Dominant Optic Atrophy

Dominant optic atrophy typically presents:

• Earlier in life
• With bilateral symmetric visual loss
• Temporal disc pallor
• Color dysfunction

Family history and genetic testing may support:

OPA1-associated disease.

Distinguishing It From Optic Neuritis

Typical demyelinating optic neuritis more often causes:

• Acute/subacute unilateral loss
• Pain with eye movement
• RAPD
• MRI optic nerve enhancement

Toxic-nutritional disease is more typically:

Bilateral, symmetric, painless, and slowly progressive.

Distinguishing It From Macular Disease

Both maculopathy and toxic optic neuropathy may cause:

• Central blur
• Central scotoma
• Color disturbance

Clues to optic nerve disease include:

• RAPD when asymmetric
• Disproportionate dyschromatopsia
• Ganglion cell/RNFL loss
• Relatively normal macular structural imaging

First Treatment Principle

The central management strategy is:

Identify and remove the offending toxin or correct the nutritional deficiency as early as possible.

Axonal injury may become irreversible if exposure continues.

Medication-Induced Disease

If a prescribed drug is suspected:

• Coordinate with the prescribing physician
• Stop or substitute the agent when medically safe
• Treat the underlying condition with an alternative regimen

Never discontinue essential therapy without considering the systemic indication.

Nutritional Treatment

Treatment should correct the:

Specific deficiency

rather than relying only on a nonspecific multivitamin.

Examples include:

• Vitamin B12 replacement
• Folate replacement
• Copper replacement
• Thiamine replacement

Dietary rehabilitation and treatment of the cause of malabsorption are equally important.

Why “High-Protein Diet + B Vitamins” Is Too Simplistic

Older recommendations emphasized a general high-protein diet and B-complex supplementation.

Modern management instead focuses on:

• Identifying the actual deficiency
• Correcting it adequately
• Treating malabsorption
• Addressing alcohol or dietary factors
• Monitoring biochemical recovery

Role of Corticosteroids

Corticosteroids are:

Not standard treatment

for uncomplicated toxic or nutritional optic neuropathy.

They should only be used when another steroid-responsive diagnosis is established.

Follow-Up After Removing the Cause

Monitor:

• Visual acuity
• Color vision
• Visual fields
• OCT RNFL/GCC
• Nutritional laboratory values when relevant

Recovery may continue for:

Several months.

Can Vision Recover?

Prognosis is highly variable.

Better recovery is associated with:

• Early recognition
• Mild initial loss
• Rapid removal of the toxin
• Prompt correction of deficiency

Some patients regain substantial vision.

Others develop permanent:

Optic atrophy and central visual loss.

Why Vision May Worsen After the Drug Is Stopped

Axonal injury already initiated before drug cessation may continue for a period.

This is particularly recognized with some drug toxicities, including:

Ethambutol.

Therefore immediate lack of improvement does not necessarily mean treatment has failed.

Emergency Red Flags

Urgent medical evaluation is required with:

• Suspected methanol ingestion
• Severe metabolic acidosis
• Acute bilateral visual loss with systemic illness
• Altered mental status
• Respiratory distress
• Seizures
• Coma

Methanol poisoning can be:

Fatal as well as blinding.

Long-Term Complications

Potential consequences include:

• Persistent cecocentral scotoma
• Dyschromatopsia
• Temporal optic atrophy
• Severe permanent visual impairment
• Peripheral neuropathy
• Myelopathy
• Cognitive dysfunction

The systemic complications depend on the underlying toxin or deficiency.

High-Yield Takeaways

• Toxic and nutritional optic neuropathies classically cause painless, bilateral, symmetric central visual loss with dyschromatopsia and cecocentral scotomas.
• The preferential site of injury is the papillomacular bundle, largely because of its vulnerability to mitochondrial dysfunction.
• The optic discs may initially look normal; later disease produces temporal or diffuse optic atrophy.
• Important drug causes include ethambutol and linezolid, with several other medications implicated less commonly.
• Ethambutol toxicity is strongly associated with dose, treatment duration, and renal impairment and requires early recognition.
• New central blur, impaired reading, or red-green color loss during ethambutol therapy warrants urgent assessment and prompt drug withdrawal in coordination with the treating team.
• Visual recovery after ethambutol toxicity is possible but not guaranteed, and progression can continue temporarily after cessation.
• Methanol poisoning is the major toxic-alcohol ophthalmic emergency and causes severe metabolic acidosis plus retinal/optic nerve toxicity.
• Methanol treatment includes fomepizole, correction of acidosis, folate/folinic acid, and hemodialysis when indicated.
• Ethylene glycol is also life-threatening but is more characteristically associated with renal failure and calcium oxalate toxicity than a classic toxic optic neuropathy.
• The older diagnosis of “tobacco-alcohol amblyopia” is better understood as nutritional optic neuropathy, sometimes compounded by tobacco-related toxicity.
• Important deficiencies include vitamin B12, folate, copper, and thiamine.
• Bariatric surgery should raise particular concern for B12 and copper deficiency.
• Laboratory evaluation should be targeted and may include B12, methylmalonic acid, folate, copper, thiamine, CBC, and renal/metabolic testing.
• OCT may show ganglion cell loss and later temporal RNFL thinning, while visual fields classically demonstrate a central or cecocentral defect.
• MRI is mainly useful to exclude compressive, inflammatory, or other neurologic causes when the presentation is atypical.
• PDE-5 inhibitors are not a typical cause of toxic optic neuropathy; their reported ocular association is primarily with NAION, and causality remains debated.
• Steroids are not routine therapy for toxic-nutritional optic neuropathy.
• The key treatment is always rapid withdrawal of the offending toxin or medication and correction of the specific nutritional deficiency.
• Early recognition offers the best chance of visual recovery; once established, optic atrophy may be permanent.

Ophthalmology – Toxic Keratoconjunctivitis

What the Disorder Represents

Toxic keratoconjunctivitis is an inflammatory and epithelial ocular-surface reaction caused by direct toxicity from a topical medication, preservative, contact lens product, cosmetic, chemical, or environmental irritant.

It may involve:

• Bulbar conjunctiva
• Palpebral conjunctiva
• Corneal epithelium
• Eyelid/periocular skin

A commonly used related term is:

Toxic medicamentosa

when the reaction results from repeated topical ophthalmic therapy.

How the Injury Develops

The main mechanism is usually:

Direct epithelial toxicity and ocular-surface inflammation

rather than a classic antigen-specific allergic reaction.

Toxic substances can disrupt:

• Corneal epithelial cells
• Conjunctival epithelial cells
• Goblet cells
• Tear-film stability

Chronic exposure may produce:

Epithelial breakdown → inflammation → tear-film dysfunction → additional epithelial toxicity

creating a self-perpetuating cycle.

Toxic vs Allergic Reactions

These mechanisms frequently overlap.

Toxic Reaction

Usually related to:

• Concentration
• Frequency
• Duration of exposure
• Preservative load

and commonly produces:

• Burning
• Diffuse punctate keratopathy
• Conjunctival injection

Allergic/Delayed Hypersensitivity Reaction

More likely to produce:

• Itching
• Eyelid dermatitis
• Follicular or papillary conjunctivitis
• Periocular edema

Some topical medications can produce:

Both toxic and allergic ocular-surface disease.

Common Medication Causes

Frequently implicated topical medications include:

• Brimonidine
• Apraclonidine
• Aminoglycosides such as gentamicin and tobramycin
• Neomycin-containing preparations
• Antiviral drops such as trifluridine
• Chronic topical anesthetic misuse
• Multiple glaucoma medications

Risk rises when several drops are used simultaneously.

Why Glaucoma Patients Are Particularly Vulnerable

Patients with glaucoma may use several topical agents for years.

Chronic exposure can produce:

• Tear-film instability
• Conjunctival inflammation
• Superficial punctate keratitis
• Meibomian gland dysfunction
• Conjunctival fibrosis

The problem is frequently related as much to:

Preservative exposure

as to the active medication itself.

Benzalkonium Chloride Toxicity

Benzalkonium chloride (BAK) is one of the most important ophthalmic preservatives associated with chronic ocular-surface toxicity.

Repeated exposure can cause:

• Epithelial cell injury
• Reduced goblet-cell density
• Tear-film instability
• Conjunctival inflammation
• Corneal punctate epitheliopathy

Risk increases with:

• Higher concentrations
• More frequent dosing
• Multiple preserved medications
• Long treatment duration

Modern Prevention Strategy

When chronic topical therapy is necessary, reduce preservative burden when possible by using:

• Preservative-free formulations
• Lower-frequency regimens
• Fixed-combination drops
• Non-BAK-preserved preparations

This is particularly important in patients with:

• Dry eye
• Ocular surface disease
• Prior corneal surgery
• Long-term glaucoma treatment

Contact Lens–Associated Toxicity

Toxic keratoconjunctivitis may occur from:

• Contact lens disinfectants
• Cleaning solutions
• Preservatives
• Improperly neutralized hydrogen peroxide
• Chemical contamination of a lens
• Lens overwear

Typical findings include:

• Burning after lens insertion
• Diffuse punctate epithelial staining
• Redness
• Contact lens intolerance

Hydrogen Peroxide Lens Injury

Failure to fully neutralize a hydrogen peroxide contact lens system can cause an acute:

Chemical epithelial injury

with:

• Severe burning
• Tearing
• Conjunctival injection
• Diffuse corneal epithelial staining

The lens should be removed immediately and the ocular surface irrigated if exposure is recent.

Cosmetic and Periocular Causes

Possible triggers include:

• Eye makeup
• Eyelash adhesives
• Cosmetic removers
• Facial creams
• Hair products
• Eyelid cleansers
• Aerosols

The history should specifically address newly introduced products.

Environmental Irritants

Examples include:

• Smoke
• Chlorine
• Air pollution
• Solvents
• Chemical fumes
• Industrial exposures

Significant chemical exposure should be treated as:

Acute chemical ocular injury

rather than routine medicamentosa.

Typical Symptoms

Patients commonly report:

• Burning
• Stinging
• Foreign-body sensation
• Redness
• Tearing
• Photophobia
• Fluctuating vision

Itching can occur but, when dominant, should raise suspicion for an allergic component.

Clues From the Timing

Symptoms may develop:

• Shortly after a new topical product
• Gradually after repeated exposure
• After increasing drop frequency
• After adding another medication

Chronic medicamentosa can be missed because the offending agent may have been used for:

Weeks or months before symptoms become obvious.

Conjunctival Findings

The conjunctiva may show:

• Diffuse injection
• Follicular reaction
• Papillary reaction
• Chemosis
• Inferior fornix inflammation

The exact appearance depends on the offending agent and whether hypersensitivity coexists.

Corneal Findings

Typical corneal changes include:

• Superficial punctate epithelial keratitis
• Diffuse fluorescein staining
• Epithelial irregularity
• Reduced tear-film stability

More severe toxicity may produce:

• Larger epithelial defects
• Delayed epithelial healing

Follicular Conjunctivitis From Medications

A chronic follicular response is particularly associated with:

• Brimonidine
• Apraclonidine
• Certain antivirals
• Other chronic topical medications

Follicles are often most prominent in the:

Inferior fornix and palpebral conjunctiva.

Eyelid and Periocular Findings

Associated signs may include:

• Eyelid erythema
• Periocular dermatitis
• Edema
• Scaling

These findings increase suspicion for:

Contact allergy or hypersensitivity

rather than pure direct toxicity.

An Important Modern Correction About Molluscum

Older descriptions sometimes listed periocular molluscum contagiosum under toxic keratoconjunctivitis.

This is misleading.

Molluscum causes a:

Chronic infectious follicular conjunctivitis

because viral proteins shed from the eyelid lesion onto the ocular surface.

It is not primarily a toxic medicamentosa.

The classic eyelid lesion is:

• Small
• Dome-shaped
• Pearly
• Umbilicated

How Molluscum-Associated Conjunctivitis Is Managed

Treatment is directed at the eyelid lesion rather than topical anti-inflammatory therapy alone.

Options include:

• Curettage
• Excision
• Other lesion-directed dermatologic therapy

Conjunctivitis usually resolves once the lesion is eliminated.

How the Diagnosis Is Made

Diagnosis is mainly:

Clinical

and depends on recognizing the temporal relationship between symptoms and an offending exposure.

The most useful diagnostic step is often:

Removing the suspected culprit and observing for improvement.

Important History Questions

Ask about:

• Every prescription eye drop
• Over-the-counter eye drops
• Artificial tears
• Contact lens solutions
• Cosmetic products
• Eyelid cleansers
• Occupational chemical exposure
• Frequency and duration of use
• Recent change in formulation or manufacturer

Patients may overlook nonprescription products unless specifically asked.

Fluorescein Examination

Fluorescein may reveal:

• Diffuse punctate epithelial staining
• Confluent epithelial disease
• Larger defects in severe cases

The staining pattern can help distinguish toxicity from:

• Exposure
• Dry eye
• Infectious keratitis

Laboratory Testing

Routine laboratory testing is:

Not required

in typical toxic keratoconjunctivitis.

Cultures or corneal scraping should be considered when there is concern for:

Infectious keratitis.

Important Diagnostic Alternatives

The differential diagnosis includes:

• Viral conjunctivitis
• Allergic conjunctivitis
• Bacterial conjunctivitis
• Dry eye disease
• Blepharitis
• Contact lens overwear
• Exposure keratopathy
• Adenoviral keratoconjunctivitis
• Early microbial keratitis

Distinguishing It From Viral Conjunctivitis

Viral disease more commonly produces:

• Acute contagious onset
• Follicular conjunctivitis
• Preauricular lymphadenopathy
• Watery discharge
• Recent sick contact

Toxic disease is more strongly associated with:

Medication or chemical exposure.

Distinguishing It From Allergic Conjunctivitis

Allergy typically produces:

• Prominent itching
• Papillary response
• Eyelid edema
• Stringy mucus

Toxicity more commonly produces:

• Burning
• Stinging
• Diffuse epithelial keratopathy

Overlap is common.

Distinguishing It From Dry Eye

Dry eye may cause similar:

• Burning
• Punctate staining
• Fluctuating vision

but toxic keratoconjunctivitis often has a clear relationship to:

Topical medication or chemical exposure.

Chronic toxic exposure can itself cause or worsen dry eye.

Distinguishing It From Microbial Keratitis

Urgent concern for infectious keratitis is warranted with:

• Focal stromal infiltrate
• Significant epithelial defect
• Increasing pain
• Marked photophobia
• Anterior chamber reaction
• Reduced vision

This is especially important in:

Contact lens wearers.

First Treatment Priority

The key intervention is:

Identify and remove the offending agent.

This may involve:

• Stopping a nonessential medication
• Switching to a preservative-free formulation
• Changing contact lens solution
• Stopping cosmetic products
• Avoiding environmental exposure

Do Not Simply Stop Essential Glaucoma Therapy

If a glaucoma medication is suspected, treatment should be modified in coordination with the treating eye-care clinician.

Options include:

• Switching drug class
• Preservative-free formulation
• Fixed-combination therapy
• Laser treatment such as SLT in appropriate patients

Abruptly stopping all glaucoma therapy can result in:

Dangerous IOP elevation.

Lubrication

First-line supportive treatment includes:

• Preservative-free artificial tears
• Lubricating gel
• Nighttime ointment when needed

Preservative-free products are preferred because adding additional preservative exposure can worsen the problem.

Contact Lens Holiday

Contact lenses should generally be discontinued until:

• Corneal staining resolves
• Conjunctival inflammation improves
• Symptoms settle

Before resuming lens wear, reconsider:

• Lens fit
• Replacement schedule
• Cleaning system
• Contact lens hygiene

Role of Topical Corticosteroids

A short course of a mild topical corticosteroid may be useful when inflammation is substantial and the offending agent has already been removed.

Examples include:

• Loteprednol
• Fluorometholone

Steroids should be prescribed only after:

Infectious keratitis has been reasonably excluded.

Why Steroids Need Monitoring

Topical corticosteroids can cause:

• Ocular hypertension
• Steroid-induced glaucoma
• Cataract
• Delayed epithelial healing
• Worsening of undiagnosed infection

Longer courses require:

IOP monitoring.

Role of Steroid-Sparing Therapy

Patients with chronic ocular surface inflammation after removal of the toxic exposure may occasionally benefit from:

• Topical cyclosporine
• Lifitegrast
• Other dry-eye anti-inflammatory therapies

These are not primary treatment for acute toxicity but may help when significant:

Secondary inflammatory dry eye

persists.

Severe Epithelial Toxicity

More significant corneal epithelial injury may require:

• Frequent preservative-free lubrication
• Ointment
• Temporary bandage contact lens in selected cases
• Close corneal follow-up

Persistent defects should trigger reassessment for:

• Neurotrophic keratopathy
• Infection
• Limbal stem-cell injury
• Continued toxic exposure

Toxicity From Topical Anesthetic Abuse

Repeated topical anesthetic use can cause a particularly severe toxic keratopathy.

Findings may include:

• Persistent epithelial defect
• Stromal infiltrates
• Ring infiltrate
• Corneal melt

This can mimic infection and may lead to:

Permanent visual loss or perforation.

The anesthetic must be stopped immediately.

When Urgent Referral Is Needed

Urgent ophthalmic assessment is appropriate when there is:

• Reduced vision
• Significant pain
• Photophobia
• Stromal infiltrate
• Large epithelial defect
• Corneal thinning
• Contact lens-associated keratitis
• Failure to improve after removal of the suspected agent

Expected Time to Improvement

Mild toxic medicamentosa often begins improving within:

Several days after removing the offending exposure.

More chronic disease may require:

• Weeks
• Occasionally longer

for the ocular surface to recover fully.

Follow-Up Approach

Follow-up depends on severity.

Mild disease may be reviewed after:

• Several days to 1–2 weeks

Closer review is necessary when there is:

• Significant corneal involvement
• Steroid treatment
• Glaucoma therapy modification
• Persistent epithelial disease

What to Monitor

Follow:

• Visual acuity
• Corneal staining
• Conjunctival inflammation
• Epithelial healing
• IOP when steroids are used
• IOP if glaucoma medications have been modified

Expected Outcome

The prognosis is generally:

Excellent

when the toxic agent is identified and removed promptly.

The ocular surface usually returns toward baseline without permanent visual impairment.

When Permanent Damage Can Occur

Chronic or severe toxicity may occasionally cause:

• Persistent epithelial disease
• Corneal scarring
• Limbal stem-cell dysfunction
• Secondary dry eye
• Reduced vision

Severe injury is particularly associated with:

• Chemical burns
• Topical anesthetic abuse
• Prolonged exposure to highly toxic preparations

High-Yield Takeaways

• Toxic keratoconjunctivitis is an ocular-surface inflammatory and epithelial reaction caused by direct toxicity from medications, preservatives, contact lens products, cosmetics, or environmental irritants.
• Chronic topical ophthalmic therapy can produce toxic medicamentosa, particularly when multiple preserved drops are used.
• Benzalkonium chloride (BAK) is an important cause of chronic epithelial and conjunctival toxicity.
• Typical symptoms are burning, stinging, foreign-body sensation, redness, tearing, and fluctuating vision.
• Common signs include diffuse conjunctival injection, follicular or papillary reaction, and superficial punctate keratitis.
• Brimonidine and apraclonidine are particularly associated with chronic follicular conjunctivitis.
• Contact lens solutions can cause toxic epitheliopathy; inadequately neutralized hydrogen peroxide can cause an acute chemical ocular-surface injury.
• Periocular molluscum contagiosum causes infectious follicular conjunctivitis rather than true toxic keratoconjunctivitis.
• Diagnosis is primarily clinical and depends heavily on identifying the offending exposure.
• The cornerstone of treatment is removal or substitution of the causative agent.
• In glaucoma patients, do not simply discontinue pressure-lowering therapy; consider preservative-free alternatives, different drug classes, or other IOP-lowering strategies.
• Preservative-free artificial tears are the preferred supportive treatment.
• A contact lens holiday is appropriate until corneal and conjunctival inflammation resolves.
• Short-course topical corticosteroids may be useful for substantial inflammation, but only after infectious keratitis has been excluded.
• Significant pain, visual decline, a focal stromal infiltrate, or a large epithelial defect should prompt urgent evaluation for microbial keratitis or severe toxic injury.
• Topical anesthetic abuse can cause severe corneal toxicity, melting, and perforation and must be recognized promptly.
• Most cases resolve with removal of the offending exposure, and the overall visual prognosis is excellent.

Ophthalmology – Toxic Anterior Segment Syndrome

What the Disorder Represents

Toxic anterior segment syndrome (TASS) is an acute, sterile postoperative inflammatory reaction caused by a toxic substance introduced into the eye during or around anterior segment surgery.

It most commonly follows:

• Cataract surgery
• Intraocular lens implantation
• Glaucoma surgery
• Corneal/anterior segment procedures

The defining features are:

• Severe sterile anterior chamber inflammation
• Diffuse corneal edema
• Little or no vitreous inflammation
• Usually very early postoperative onset

The most important diagnostic challenge is distinguishing it from:

Acute postoperative infectious endophthalmitis.

When It Usually Appears

TASS classically begins:

Within 12–48 hours after surgery

and often becomes evident on:

Postoperative day 1.

This rapid onset is an important clue.

However, delayed cases can occur depending on:

• Type of contaminant
• Retained toxic material
• Surgical procedure

Therefore timing alone cannot establish the diagnosis.

Why It Can Occur in Clusters

TASS is uncommon overall but may appear as:

An outbreak affecting several patients operated on at the same surgical facility.

A cluster strongly suggests a shared exposure involving:

• Instrument cleaning
• Sterilization
• Irrigating solutions
• Medications
• Ophthalmic viscosurgical devices
• Intraocular lenses

Every suspected cluster requires systematic investigation.

What Causes the Inflammation

TASS is caused by exposure of anterior segment tissues to a substance that is:

• Toxic
• Incorrectly concentrated
• Contaminated
• Chemically incompatible
• Incompletely removed from surgical instruments

The resulting injury produces:

Direct toxic damage → breakdown of the blood-aqueous barrier → intense sterile inflammation

Which Structures Are Most Vulnerable

Toxic injury may affect:

• Corneal endothelium
• Iris
• Ciliary body
• Trabecular meshwork

Severe endothelial damage can cause:

Permanent corneal edema

while trabecular injury can lead to:

Secondary glaucoma.

Common Sources of TASS

Potential causes include:

• Residual detergents or enzymatic cleaners
• Inadequately rinsed surgical instruments
• Bacterial endotoxin
• Preservatives in intraocular medications
• Incorrect drug concentration
• Inappropriate pH
• Abnormal osmolality
• Denatured ophthalmic viscosurgical devices
• Intraocular lens residues
• Oxidized metal deposits
• Contaminated irrigating solutions

Instrument Reprocessing as a Major Cause

A particularly important source is:

Improper cleaning and sterilization of reusable ophthalmic instruments.

Problems may include:

• Enzymatic detergent residue
• Inadequate flushing of cannulas
• Retained viscoelastic or biologic material
• Contaminated steam sterilization systems

Small-bore instruments are especially vulnerable to retained residues.

Medication-Related Causes

Any substance placed:

• On the ocular surface
• Into the anterior chamber
• Around the eye

may potentially contribute.

Examples include:

• Intracameral antibiotics
• Anesthetic preparations
• Balanced salt solutions
• Dilating agents
• Epinephrine-containing solutions

The important issue is often not the drug itself but:

Its concentration, preservative content, pH, or preparation error.

Why Preservatives Matter

Medications intended for topical use may contain preservatives that are toxic when injected intraocularly.

For this reason:

Only appropriately formulated preservative-free preparations should be used intraocularly.

Typical Patient Symptoms

Patients may notice:

• Blurred vision
• Photophobia
• Ocular discomfort
• Redness

Pain is often:

Mild or absent

compared with infectious endophthalmitis.

However, pain intensity is not sufficiently reliable to separate the two conditions.

Characteristic Corneal Finding

One of the most useful signs is:

Diffuse limbus-to-limbus corneal edema

caused by widespread endothelial toxicity.

This may be accompanied by:

• Descemet folds
• Markedly reduced corneal clarity

Diffuse edema extending across the entire cornea strongly favors TASS over routine postoperative inflammation.

Anterior Chamber Findings

The anterior chamber may show:

• Marked cells and flare
• Fibrin
• Hypopyon
• Pigment
• Iris inflammation

Despite the severe appearance, this inflammation is:

Sterile.

Hypopyon Does Not Mean Infection

A hypopyon may occur in both:

• TASS
• Infectious endophthalmitis

Therefore the presence of hypopyon alone does:

Not distinguish them.

Clinical context and posterior segment findings are critical.

Pupillary Abnormalities

Severe iris toxicity may produce:

• Poor pupillary reaction
• Iris atrophy
• Fixed dilated pupil

A persistent postoperative fixed pupil is sometimes referred to as:

Urrets-Zavalia-like syndrome

when associated with ischemic or toxic iris injury.

Intraocular Pressure Changes

IOP may be:

• Elevated
• Occasionally initially low

Elevation can result from:

• Trabecular inflammation
• Toxic trabecular damage
• Inflammatory debris

Persistent damage may produce:

Chronic secondary glaucoma.

Vitreous Findings

Classic TASS is largely confined to the:

Anterior segment

Therefore significant:

• Vitritis
• Dense vitreous haze

should strongly increase suspicion for:

Infectious endophthalmitis.

Important Diagnostic Principle

If there is uncertainty between TASS and endophthalmitis:

Manage the case as possible infectious endophthalmitis until infection is reasonably excluded.

Missing endophthalmitis can cause catastrophic permanent vision loss.

TASS vs Infectious Endophthalmitis – Timing

TASS

Typically:

12–48 hours after surgery

Infectious Endophthalmitis

More commonly:

Several days after surgery

often around postoperative days 2–7.

However:

There is substantial overlap.

Very early infection can occur, and delayed TASS is possible.

TASS vs Endophthalmitis – Pain

TASS

• Often mild discomfort
• Severe pain less typical

Endophthalmitis

• Pain more common
• May be substantial

But:

Pain is neither sensitive nor specific enough to rule infection in or out.

TASS vs Endophthalmitis – Corneal Edema

TASS

• Diffuse limbus-to-limbus edema
• Often severe from endothelial toxicity

Endophthalmitis

• Corneal edema may occur
• Often less uniformly diffuse early

This is one of the more helpful distinguishing signs.

TASS vs Endophthalmitis – Vitreous

TASS

• Minimal or absent vitritis

Endophthalmitis

• Vitritis is common
• Red reflex may be reduced
• Fundus view may become hazy

Significant vitreous inflammation strongly favors infection.

TASS vs Endophthalmitis – Eyelid and Adnexal Findings

TASS generally produces little:

• Eyelid edema
• Orbital tenderness
• Adnexal inflammation

Infectious endophthalmitis may have more pronounced:

• Lid edema
• Conjunctival injection
• Chemosis

but considerable overlap exists.

How the Diagnosis Is Made

Diagnosis is based on:

1. Recent intraocular surgery
2. Very early postoperative inflammation
3. Diffuse corneal edema
4. Severe anterior chamber reaction
5. Little or no vitreous involvement
6. Rapid response to corticosteroids
7. Investigation excluding infection when necessary

Role of Cultures

If infectious endophthalmitis cannot be confidently excluded, obtain:

• Aqueous sample
• Vitreous sample

for:

• Gram stain
• Culture
• Additional molecular testing where available

Important Modern Correction About Negative Cultures

A negative culture does:

Not prove TASS.

Culture-negative infectious endophthalmitis occurs.

Therefore diagnosis cannot be based simply on:

“Cultures negative = TASS.”

When B-Scan Ultrasound Is Useful

If the posterior segment cannot be visualized, B-scan ultrasonography can assess for:

• Vitreous opacities
• Retinal detachment
• Choroidal detachment

Marked vitreous echogenicity may support:

Endophthalmitis, although ultrasound findings are not entirely specific.

First Treatment Priority

Once infection has been judged unlikely, the main treatment is:

Immediate intensive topical corticosteroid therapy.

Examples include frequent:

• Prednisolone acetate
• Difluprednate

depending on severity.

Initial dosing may be as frequent as:

Every 30–60 minutes

in severe disease.

Why Steroids Work

Because TASS is:

Sterile inflammatory toxicity

rapid suppression of inflammation can reduce:

• Fibrin formation
• Posterior synechiae
• Additional endothelial injury
• Trabecular damage

Treatment is generally tapered according to clinical response.

Cycloplegia

Cycloplegic agents may be useful when there is significant anterior uveitis to:

• Reduce ciliary spasm
• Improve comfort
• Reduce posterior synechiae formation

Managing Elevated IOP

Elevated IOP may require:

• Topical beta-blocker
• Carbonic anhydrase inhibitor
• Alpha-2 agonist when appropriate
• Oral acetazolamide for substantial elevation

The choice depends on:

• Severity
• Corneal condition
• Patient comorbidities

Role of Oral or Systemic Steroids

Systemic corticosteroids are:

Not routinely required

for uncomplicated TASS.

They may occasionally be considered for unusually severe inflammation, but intensive topical therapy is the mainstay.

When the Diagnosis Is Uncertain

If endophthalmitis remains a meaningful possibility, do not rely solely on steroids.

The patient may require:

• Vitreous/aqueous sampling
• Intravitreal antibiotics
• Retina consultation

depending on clinical severity.

How Quickly It Should Improve

TASS often responds noticeably to intensive corticosteroids within:

24–48 hours

with improvement in:

• Anterior chamber inflammation
• Corneal edema
• Visual function

Failure to improve should trigger reassessment for:

• Infection
• Severe irreversible endothelial injury
• Retained toxic material
• Another postoperative complication

Why Follow-Up Must Be Close

Patients with suspected TASS should initially be reviewed:

Daily or very frequently

until the diagnosis is secure and the inflammation clearly improves.

Monitor:

• Visual acuity
• Corneal edema
• Anterior chamber reaction
• IOP
• Posterior segment

Persistent Corneal Edema

Severe endothelial toxicity may lead to:

Permanent endothelial decompensation.

Signs include:

• Persistent stromal edema
• Epithelial bullae
• Reduced endothelial cell count
• Chronic blurred vision

Corneal Surgery for Permanent Damage

If irreversible corneal decompensation develops, treatment may require endothelial keratoplasty such as:

• DMEK
• DSAEK

Penetrating keratoplasty is now usually reserved for cases where endothelial keratoplasty is unsuitable or additional full-thickness corneal pathology exists.

Important Modern Correction About Corneal Transplantation

Older descriptions emphasized:

DSEK or penetrating keratoplasty

Modern treatment usually favors:

DMEK or DSAEK

when the main problem is endothelial failure.

Secondary Glaucoma

Toxic injury to the trabecular meshwork can cause:

• Persistent IOP elevation
• Chronic glaucoma

Management may require:

• Multiple topical medications
• Laser in selected eyes
• Glaucoma surgery

depending on severity.

Iris Damage

Severe anterior segment toxicity may result in:

• Iris atrophy
• Fixed dilated pupil
• Photophobia
• Glare

These changes may be permanent.

Posterior Synechiae

Severe fibrinous inflammation may produce:

• Posterior synechiae
• Irregular pupil
• Pupillary block in extreme cases

Prompt anti-inflammatory and cycloplegic therapy helps reduce this risk.

Cystoid Macular Edema

Although TASS is primarily an anterior segment disorder, postoperative inflammation can occasionally be associated with:

Cystoid macular edema

which should be assessed with OCT if visual recovery is less than expected once the cornea clears.

What to Do When Several Cases Occur

A suspected outbreak should trigger:

Immediate investigation of the surgical system.

Review:

• Instrument cleaning protocols
• Sterilization processes
• Enzymatic detergent use
• Cannula flushing
• Balanced salt solutions
• Intraocular medications
• Viscoelastic agents
• IOL lots
• Medication compounding
• Operating room workflow

Why Root-Cause Investigation Matters

Treating affected patients is only one part of management.

The larger goal is to identify and eliminate the source to prevent:

Additional cases.

Prevention Through Instrument Processing

Key measures include:

• Thorough cleaning immediately after use
• Adequate flushing of lumened instruments
• Avoidance of retained detergent
• Correct sterilization cycles
• Proper maintenance of sterilization equipment

Ophthalmic instruments require particularly careful processing because:

Very small amounts of residual material can be toxic intraocularly.

Prevention Through Medication Safety

Before intraocular administration, confirm:

• Correct drug
• Correct concentration
• Correct dilution
• Appropriate pH
• Appropriate osmolality
• Preservative-free formulation
• Correct compounding and storage

Medication preparation errors can create outbreaks affecting multiple patients.

Expected Outcome

Visual prognosis depends on the severity of:

• Endothelial toxicity
• Trabecular injury
• Iris damage
• Inflammatory response

Mild and moderate cases often recover well with:

Prompt intensive corticosteroid treatment.

Features Associated With Worse Prognosis

Poorer outcomes are more likely with:

• Severe initial corneal edema
• Extensive endothelial cell loss
• Markedly elevated IOP
• Fixed pupil
• Delayed treatment
• Persistent severe inflammation

Major Long-Term Complications

Potential complications include:

• Permanent corneal edema
• Endothelial failure
• Secondary glaucoma
• Iris atrophy
• Fixed dilated pupil
• Posterior synechiae
• Cystoid macular edema
• Permanent visual loss in severe cases

High-Yield Takeaways

• TASS is an acute sterile inflammatory reaction of the anterior segment caused by toxic exposure during or around intraocular surgery.
• It most commonly appears within 12–48 hours after cataract surgery, often on postoperative day 1.
• TASS may occur in clusters, making surgical-system investigation crucial.
• Common causes include residual detergents, bacterial endotoxin, preservatives, incorrect drug concentration, abnormal pH/osmolality, contaminated solutions, and instrument-processing errors.
• The classic examination shows severe anterior chamber inflammation with diffuse limbus-to-limbus corneal edema.
• Hypopyon can occur and does not by itself distinguish TASS from infectious endophthalmitis.
• Minimal or absent vitritis strongly favors TASS; significant vitreous inflammation raises concern for endophthalmitis.
• TASS often presents earlier than postoperative endophthalmitis, but timing alone is not sufficient for diagnosis.
• A negative culture does not prove TASS, because infectious endophthalmitis may also be culture-negative.
• When the diagnosis is uncertain, it is safer to manage the patient as possible infectious endophthalmitis until infection is adequately excluded.
• Once TASS is established, treatment consists primarily of immediate intensive topical corticosteroids, often administered hourly or more frequently initially.
• IOP should be monitored closely because trabecular toxicity can cause acute or chronic glaucoma.
• Persistent corneal edema may reflect irreversible endothelial damage and may ultimately require DMEK or DSAEK.
• Severe iris injury may cause a permanently fixed dilated pupil.
• Failure to improve promptly with steroids should trigger reassessment of the diagnosis.
• A TASS outbreak demands a detailed review of instrument cleaning, sterilization, intraocular medications, viscoelastic agents, irrigation solutions, and compounding procedures.
• The major principle is: early TASS can look dramatic but is sterile; early endophthalmitis can look similar and must never be missed.

Ophthalmology – Tilted Disc Syndrome

What the Disorder Represents

Tilted disc syndrome (TDS) is a congenital optic nerve head anomaly characterized by oblique insertion of the optic nerve into the globe, producing a characteristically:

• Oval, tilted optic disc
• Inferonasal displacement of part of the disc
• Superior or superotemporal elevation
• Inferior or inferonasal peripapillary crescent
• Abnormal retinal vessel orientation
• Associated inferonasal chorioretinal thinning or ectasia

It is frequently associated with:

Myopia and myopic astigmatism.

⸻

How the Disc Typically Looks

The optic nerve head commonly has:

• Oblique long axis
• Inferonasal tilt
• Apparent superior elevation
• Inferior or inferonasal crescent
• Irregular disc margins

The configuration may give the false impression of:

• Optic disc edema
• Optic nerve hypoplasia
• Glaucomatous cupping

⸻

Why the Optic Disc Is Tilted

TDS is thought to result from abnormal development of the:

• Optic nerve insertion
• Posterior sclera
• Peripapillary choroid and RPE

The exact embryologic mechanism remains uncertain.

It has historically been considered related to incomplete closure or abnormal development of the:

Embryonic fissure

although it is distinct from a true optic disc coloboma.

⸻

Posterior Scleral Ectasia

Many affected eyes show inferonasal:

Posterior scleral ectasia

or a localized staphyloma-like configuration.

This produces distortion of:

• Retina
• Choroid
• RPE
• Visual field mapping

and contributes to the characteristic refractive and field abnormalities.

⸻

Typical Refractive Error

The most common refractive association is:

Myopic astigmatism

The astigmatism may arise partly from:

• Abnormal posterior globe contour
• Oblique disc insertion
• Regional retinal ectasia

Anisometropia may occur and can produce:

Amblyopia in children.

⸻

Laterality

Tilted discs are commonly:

Bilateral

although asymmetry is frequent.

One eye may appear much more tilted than the other.

⸻

Situs Inversus of Retinal Vessels

A classic associated finding is:

Situs inversus of the retinal vessels

in which vessels initially emerge from the disc in an abnormal direction before turning toward their usual retinal territories.

This is particularly characteristic when combined with:

• Inferonasal tilt
• Peripapillary crescent
• Myopic astigmatism

⸻

Peripapillary Chorioretinal Changes

The inferonasal fundus may show:

• RPE hypopigmentation
• Choroidal thinning
• Peripapillary atrophy
• Localized ectasia

These abnormalities correspond anatomically to many of the characteristic:

Visual field defects.

⸻

What Patients Usually Notice

Many patients are:

Asymptomatic

and the diagnosis is made incidentally.

Others may have:

• Blurred vision from myopia or astigmatism
• Reduced best-corrected acuity
• Amblyopia
• Strabismus
• Visual field abnormalities

⸻

Visual Acuity

Visual acuity can range from:

• Normal
• Mildly reduced
• Moderately reduced

Reduction may result from:

• Uncorrected refractive error
• Amblyopia
• Associated macular or chorioretinal abnormalities

The tilted disc itself does not necessarily cause poor central acuity.

⸻

Characteristic Visual Field Defects

TDS may produce:

• Superotemporal field defects
• Bitemporal-appearing defects
• Superior arcuate-like defects
• Enlarged blind spot

The classic bilateral pattern may resemble:

Incomplete bitemporal hemianopia.

⸻

Why the Field Can Mimic Chiasmal Disease

The inferonasal retinal ectasia can generate a corresponding:

Superotemporal visual field defect

in each eye.

Together, these may simulate:

Bitemporal field loss

and therefore raise concern for a chiasmal lesion.

⸻

The Key Distinction From Chiasmal Hemianopia

Field defects caused by tilted disc syndrome commonly:

Do not precisely respect the vertical meridian.

A true chiasmal lesion much more characteristically produces:

A vertical-meridian-respecting temporal field defect.

This distinction is clinically important.

⸻

Refractive Field Artifacts

Some visual field abnormalities can improve when appropriate refractive correction is placed during testing.

This occurs because posterior ectasia and myopic astigmatism may produce:

Localized refractive defocus

that exaggerates apparent field loss.

Therefore visual field testing should be performed using:

Accurate refractive correction.

⸻

Static vs Kinetic Perimetry

Both automated and kinetic perimetry can be useful.

Kinetic perimetry may help demonstrate:

• Irregular midperipheral defects
• Refractive scotoma behavior
• Non-neurologic field patterns

Automated perimetry is generally more practical for serial monitoring.

⸻

Optical Coherence Tomography

OCT can be useful but must be interpreted cautiously.

Tilted discs may cause:

• Abnormal RNFL distribution
• Apparent sectoral thinning
• Segmentation errors
• Disc-center misidentification

These can create false-positive:

“Red disease” on glaucoma OCT reports.

⸻

Why Glaucoma Diagnosis Can Be Difficult

Myopic tilted discs frequently resemble glaucomatous nerves because they may have:

• Apparent rim thinning
• Peripapillary atrophy
• Abnormal RNFL profiles
• Unusual cupping

A single abnormal OCT scan should not establish glaucoma.

Diagnosis should instead integrate:

• IOP
• Optic nerve appearance
• Serial photographs
• Visual fields
• OCT progression analysis

⸻

Macular Ganglion Cell Analysis

Macular ganglion cell analysis may provide useful complementary information when peripapillary RNFL interpretation is difficult.

However, high myopia and posterior globe deformation can also create:

Macular segmentation artifacts.

Careful review of the raw scans is essential.

⸻

Fundus Photography

Disc photography is useful for:

• Documenting baseline anatomy
• Comparing changes over time
• Distinguishing congenital appearance from progressive optic neuropathy

A stable tilted disc over years strongly supports a congenital anomaly.

⸻

Role of B-Scan or Other Imaging

Ultrasound is generally unnecessary.

Ocular imaging such as:

• OCT
• Fundus photography
• Wide-field imaging

is usually sufficient to document the anomaly.

⸻

When Neuroimaging Is Necessary

MRI of the brain and optic pathways should be considered when the visual field:

• Clearly respects the vertical meridian
• Is progressive
• Is inconsistent with the disc anatomy
• Is associated with neurologic symptoms
• Is accompanied by unexplained reduced acuity or color vision

The purpose is to exclude:

Chiasmal or retrochiasmal disease.

⸻

Important Modern Clinical Principle

Do not attribute a temporal field defect automatically to a tilted disc.

If the pattern looks neurologically typical, especially when it:

Respects the vertical meridian

the patient should be investigated for:

• Pituitary adenoma
• Suprasellar mass
• Other chiasmal pathology

⸻

Conditions That Can Look Similar

Important differential diagnoses include:

• Optic disc coloboma
• Optic nerve hypoplasia
• Morning glory disc anomaly
• Myopic optic disc
• Glaucoma
• Optic disc edema
• Optic disc drusen
• Chiasmal visual field disease

⸻

Distinguishing It From Optic Disc Coloboma

Tilted Disc

• Oblique disc orientation
• Inferonasal crescent
• Situs inversus vessels
• Myopic astigmatism

Optic Disc Coloboma

• Excavated congenital defect
• Usually inferonasal
• More clearly cavitary
• May be associated with retinochoroidal coloboma

⸻

Distinguishing It From Morning Glory Disc Anomaly

Morning glory disc typically has:

• Funnel-shaped excavation
• Central glial tuft
• Radially oriented vessels
• Peripapillary pigment ring

This is quite different from the more subtle oblique insertion seen in TDS.

⸻

Distinguishing It From Optic Nerve Hypoplasia

Optic nerve hypoplasia usually shows:

• Small optic disc
• Double-ring sign
• Reduced number of nerve fibers

TDS instead shows an:

Obliquely inserted, oval disc

rather than simply a small nerve.

⸻

Distinguishing It From Glaucoma

Tilted discs may show apparent:

• Cupping
• RNFL thinning
• Field defects

but congenital defects are typically:

Stable over time.

Progressive structural or functional change favors true glaucoma.

⸻

Genetic Associations

TDS is usually:

Sporadic

and has no established routine Mendelian inheritance pattern.

Tilted discs have been reported in association with certain inherited retinal disorders, including congenital stationary night blindness, but such associations are:

Uncommon and not diagnostic of TDS itself.

⸻

Is Genetic Testing Needed?

No.

Routine genetic testing is:

Not indicated for isolated tilted disc syndrome.

Testing may be appropriate only if additional features suggest:

• Inherited retinal disease
• Syndromic disease
• Another congenital optic nerve disorder

⸻

First Management Priority

There is no treatment that changes the congenital disc anatomy.

Management therefore focuses on:

• Accurate refractive correction
• Detection and treatment of amblyopia
• Recognition of strabismus
• Appropriate interpretation of visual fields
• Avoidance of unnecessary neurologic or glaucoma treatment

⸻

Correcting Refractive Error

Myopia and astigmatism should be corrected with:

• Spectacles
• Contact lenses when appropriate

Early correction is especially important in children to maximize:

Visual development.

⸻

Amblyopia Treatment

If significant anisometropia or reduced vision causes amblyopia:

• Correct the refractive error
• Consider patching or atropine penalization when appropriate

Treatment is most effective during the:

Visual developmental period.

⸻

Strabismus

Associated strabismus can be managed with:

• Optical correction
• Prism in selected cases
• Strabismus surgery when indicated

The optic disc anomaly itself does not require surgery.

⸻

Low-Vision Support

Patients with significant bilateral visual impairment may benefit from:

• Magnification
• Electronic low-vision aids
• Contrast enhancement
• Educational accommodations

Most patients with isolated TDS do not require low-vision rehabilitation.

⸻

Follow-Up Strategy

Follow-up depends on:

• Age
• Refractive error
• Amblyopia risk
• Visual field abnormality
• Suspicion for glaucoma

Stable adults with typical isolated TDS may require only:

Periodic routine ophthalmic review.

⸻

When More Frequent Monitoring Is Needed

Closer follow-up is appropriate when there is:

• Suspicious optic nerve change
• Elevated IOP
• Progressive field abnormality
• Significant childhood amblyopia
• New visual symptoms

⸻

Posterior Segment Complications

Most patients have a stable congenital anomaly.

However, highly myopic or ectatic eyes may occasionally develop associated macular or choroidal abnormalities.

Rare complications can include:

• Choroidal neovascularization
• Progressive myopic macular change

These are not defining features of TDS.

⸻

Expected Clinical Course

Tilted disc syndrome itself is generally:

Nonprogressive

because it is a congenital structural abnormality.

Visual field defects are usually stable unless another disease develops.

⸻

Visual Prognosis

The prognosis is generally:

Good

especially when:

• Refractive error is corrected
• Amblyopia is prevented or treated
• Coexisting glaucoma or retinal disease is absent

Permanent significant visual impairment is uncommon in isolated uncomplicated TDS.

⸻

High-Yield Takeaways

• Tilted disc syndrome is a congenital anomaly of oblique optic nerve insertion, usually associated with myopia and astigmatism.
• The classic optic disc is oval and inferonasally tilted, often with an inferior/inferonasal crescent.
• Situs inversus of the retinal vessels is a characteristic associated finding.
• Inferonasal RPE/choroidal thinning and posterior scleral ectasia may accompany the disc anomaly.
• TDS may produce superotemporal or pseudo-bitemporal visual field defects.
• Unlike true chiasmal disease, TDS field defects usually do not precisely respect the vertical meridian.
• Accurate refractive correction during perimetry is important because some apparent field loss may reflect refractive defocus from posterior ectasia.
• MRI should be obtained when a temporal field defect respects the vertical meridian, progresses, or is otherwise atypical.
• OCT interpretation can be difficult because disc tilt and myopia cause RNFL segmentation errors and false-positive glaucoma classifications.
• Glaucoma should be diagnosed by longitudinal structural and functional change, not by a single abnormal OCT color map.
• Routine genetic testing is not indicated for isolated TDS.
• There is no treatment for the congenital disc tilt itself.
• Management focuses on refractive correction, amblyopia therapy when needed, and appropriate field/glaucoma surveillance.
• The condition is usually stable and nonprogressive, with a generally good visual prognosis.

Ophthalmology – Thyroid Eye Disease

What the Disorder Represents

Thyroid eye disease (TED) is an autoimmune inflammatory disorder of the orbit affecting:

• Extraocular muscles
• Orbital fat
• Orbital connective tissue
• Eyelids
• Lacrimal gland
• Ocular surface

It is also called:

• Graves orbitopathy
• Graves ophthalmopathy
• Thyroid-associated orbitopathy

The classic manifestations are:

• Upper-lid retraction
• Proptosis
• Restrictive strabismus with diplopia
• Exposure keratopathy
• In severe cases, dysthyroid optic neuropathy (DON)

Relationship to Thyroid Function

TED is most commonly associated with:

Graves hyperthyroidism

but can also occur in patients who are:

• Euthyroid
• Hypothyroid
• Occasionally associated with Hashimoto thyroiditis

Therefore:

Normal thyroid hormone levels do not exclude TED.

Ocular disease may:

• Precede thyroid dysfunction
• Develop simultaneously
• Appear after thyroid disease is diagnosed

Who Is Most Often Affected

TED is more common in:

• Women
• Middle-aged adults

but severe disease is disproportionately seen in:

• Men
• Older patients
• Smokers

Disease is usually bilateral but can be:

Markedly asymmetric or apparently unilateral.

The Most Important Modifiable Risk Factor

The strongest established modifiable risk factor is:

Cigarette smoking

Smoking increases:

• Risk of developing TED
• Disease severity
• Risk of progression
• Risk of worsening after radioactive iodine
• Poor response to treatment

Smoking cessation is therefore one of the most important components of management.

Other Factors That Increase Risk or Severity

Relevant factors include:

• Poorly controlled hyperthyroidism
• Hypothyroidism after treatment
• High TSH-receptor antibody levels
• Radioactive iodine in susceptible patients
• Diabetes
• Hypercholesterolemia
• Older age

Rapid normalization and maintenance of a:

Euthyroid state

is important.

Modern Understanding of the Autoimmune Mechanism

TED is driven by autoimmune activation of orbital fibroblasts.

Two particularly important receptors are:

• TSH receptor (TSHR)
• Insulin-like growth factor-1 receptor (IGF-1R)

Autoimmune signaling activates fibroblasts, leading to:

• Cytokine production
• Glycosaminoglycan accumulation
• Tissue edema
• Adipogenesis
• Extraocular muscle enlargement

This explains why therapies targeting:

IGF-1R

can improve proptosis and diplopia in selected patients.

Why the Orbit Becomes Crowded

Inflammatory enlargement of:

• Extraocular muscles
• Orbital fat

occurs within the fixed bony orbit.

This can produce:

• Proptosis
• Venous congestion
• Eyelid retraction
• Restrictive motility
• Corneal exposure
• Compression of the optic nerve at the orbital apex

The Two Broad Disease Phases

TED typically follows a biphasic course.

Active Inflammatory Phase

Characterized by:

• Pain
• Redness
• Swelling
• Chemosis
• Progressive proptosis
• Worsening diplopia

This phase commonly lasts:

Months to a few years

Inactive or Fibrotic Phase

Inflammation subsides, but patients may retain:

• Proptosis
• Restrictive strabismus
• Lid retraction
• Exposure
• Disfigurement

The distinction between:

Activity and severity

is critical for treatment decisions.

How Activity Is Assessed

The Clinical Activity Score (CAS) is commonly used.

Classic CAS features include:

• Spontaneous retrobulbar pain
• Pain on attempted gaze
• Eyelid erythema
• Eyelid swelling
• Conjunctival redness
• Chemosis
• Caruncular or plical inflammation

A score of:

≥3/7

is traditionally considered supportive of active disease at the initial visit.

However:

CAS is not perfect and should not be used in isolation.

Progression in:

• Proptosis
• Diplopia
• Motility restriction
• Soft-tissue inflammation

may indicate active TED even when CAS is relatively low.

How Severity Is Classified

A practical classification is:

Mild

• Minor lid retraction
• Mild soft-tissue involvement
• Mild proptosis
• Little or no diplopia
• Limited impact on daily life

Moderate-to-Severe

• Significant lid retraction
• Moderate/severe soft-tissue disease
• Meaningful proptosis
• Restrictive diplopia
• Significant quality-of-life impairment

Sight-Threatening

• Dysthyroid optic neuropathy
• Severe corneal exposure with ulceration or impending perforation

Sight-threatening TED is an:

Ophthalmic emergency.

The Most Common External Sign

The most characteristic external finding is:

Upper-eyelid retraction

which produces:

• Superior scleral show
• Staring appearance

Lower-lid retraction may also occur.

Lid Lag

Lid lag refers to delayed downward movement of the upper eyelid as the patient looks downward.

This differs from static lid retraction but commonly accompanies it.

Lagophthalmos

Incomplete eyelid closure can result from:

• Proptosis
• Lid retraction
• Fibrosis

This can lead to:

Exposure keratopathy.

Ocular Surface Manifestations

Patients often complain of:

• Grittiness
• Burning
• Tearing
• Foreign-body sensation
• Photophobia
• Fluctuating vision

Findings may include:

• Punctate epithelial keratitis
• Inferior corneal staining
• Exposure keratopathy
• Superior limbic keratoconjunctivitis

Superior Limbic Keratoconjunctivitis

TED is an important association of:

Superior limbic keratoconjunctivitis (SLK)

especially in patients with:

• Tight upper lids
• Lid retraction
• Increased superior conjunctival friction

Proptosis

Proptosis results from enlargement of:

• Orbital fat
• Extraocular muscles
• Both

It is assessed clinically with:

Hertel exophthalmometry

but normal values vary according to:

• Ethnicity
• Facial anatomy
• Instrument base measurement

Change over time is often more useful than a single absolute number.

Restrictive Strabismus

Diplopia results from inflammation and later fibrosis of extraocular muscles.

The classic order of muscle involvement is often remembered as:

Inferior rectus → medial rectus → superior rectus → lateral rectus

but any extraocular muscle can be affected.

Typical Motility Pattern

Inferior rectus restriction causes:

• Limited elevation
• Hypotropia of the affected eye

Medial rectus restriction causes:

• Limited abduction
• Esotropia

Diplopia may initially occur only in:

• Upgaze
• Lateral gaze

before affecting primary position.

Why Diplopia Is Restrictive Rather Than Paretic

The affected muscle is:

Fibrotic and mechanically tight

rather than neurologically weak.

Forced-duction testing may therefore be:

Positive.

Dysthyroid Optic Neuropathy

Dysthyroid optic neuropathy (DON) is the most important vision-threatening complication.

It usually results from:

Compression of the optic nerve by enlarged extraocular muscles at the orbital apex.

It can occasionally occur without dramatic proptosis.

Warning Signs of Optic Neuropathy

Look for:

• Reduced visual acuity
• Reduced color vision
• RAPD if asymmetric
• Reduced contrast sensitivity
• Visual-field defect
• Optic disc edema or pallor

However, the optic disc may appear:

Normal despite significant DON.

A Key Clinical Trap

The amount of proptosis does:

Not reliably predict optic nerve compression.

A patient with relatively little proptosis but a crowded orbital apex may develop severe DON.

Examination Priorities

A complete TED examination should include:

• Visual acuity
• Pupils
• Color vision
• Contrast sensitivity when available
• Ocular motility
• Alignment
• Lid position
• Lagophthalmos
• Corneal exposure
• Exophthalmometry
• IOP
• Optic nerve evaluation

Why IOP May Rise

IOP can increase due to:

• Orbital venous congestion
• Restriction of the inferior rectus
• Increased pressure during upgaze
• Coexisting glaucoma
• Steroid therapy

IOP should ideally be measured in:

Primary gaze

because forced upgaze can artificially increase the reading.

Thyroid Blood Tests

Systemic evaluation typically includes:

• TSH
• Free T4
• T3 when appropriate

Autoimmune markers may include:

• TSH-receptor antibodies (TRAb)
• Thyroid-stimulating immunoglobulin (TSI)

Positive TRAb/TSI supports the diagnosis.

Negative testing does:

Not completely exclude TED.

When Imaging Is Useful

Imaging is particularly helpful when:

• Diagnosis is atypical
• Disease is unilateral
• DON is suspected
• Surgical planning is required
• Another orbital process must be excluded

CT Appearance

Orbital CT classically shows:

Extraocular muscle belly enlargement with relative tendon sparing

producing a spindle-shaped appearance.

The most commonly enlarged muscles are:

• Inferior rectus
• Medial rectus

CT is especially useful for evaluating:

• Bony orbit
• Apical crowding
• Surgical decompression anatomy

MRI Appearance

MRI provides excellent soft-tissue detail and can help assess:

• Extraocular muscle enlargement
• Orbital fat
• Optic nerve compression
• Inflammatory activity

T2/STIR hyperintensity may support:

Active muscle inflammation.

The Classic Imaging Distinction

TED usually causes:

Muscle-belly enlargement with tendon sparing.

Idiopathic orbital myositis more commonly involves:

The muscle and its tendon insertion.

This distinction is helpful but not absolute.

Important Alternative Diagnoses

Consider:

• Idiopathic orbital inflammation
• Orbital lymphoma
• Metastasis
• Carotid-cavernous fistula
• Orbital vascular malformation
• Sarcoidosis
• IgG4-related disease
• Myasthenia gravis

Why Myasthenia Is Important

TED and myasthenia gravis can coexist.

Suspect myasthenia when there is:

• Fluctuating diplopia
• Ptosis
• Variable motility abnormalities
• Findings that do not fit a restrictive pattern

Myasthenia does not cause:

Proptosis or extraocular muscle enlargement typical of TED.

First Priorities for Every Patient

Management begins with:

• Smoking cessation
• Restoration and maintenance of euthyroidism
• Ocular surface protection
• Assessment of activity and severity
• Identification of DON or corneal threat

Treating Ocular Surface Disease

Supportive measures include:

• Preservative-free artificial tears
• Lubricating gel or ointment
• Nighttime ointment
• Moisture chambers
• Eyelid taping during sleep when needed
• Head elevation during sleep

More severe exposure may require:

• Temporary tarsorrhaphy
• Botulinum-induced protective ptosis in selected cases
• Definitive lid surgery after stabilization

Role of Selenium

For mild active TED, particularly in regions or patients with low selenium intake, a limited course of selenium may improve:

• Symptoms
• Quality of life
• Disease progression

Typical studied dosing has been approximately:

100 micrograms twice daily for 6 months

but supplementation should not be indiscriminate because excessive selenium can be toxic.

Its benefit is less certain in selenium-replete populations.

Managing Diplopia Conservatively

Temporary options include:

• Fresnel prism
• Ground-in prism when deviation is small and stable
• Occlusion in difficult cases

Prism is most useful when the deviation is:

• Relatively small
• Comitant enough to correct

Radioactive Iodine and TED

Radioactive iodine treatment for hyperthyroidism can worsen TED in susceptible patients, particularly:

• Smokers
• Patients with active disease
• Patients with high TRAb levels

When radioactive iodine is necessary in a high-risk patient, prophylactic:

Glucocorticoids

may reduce the risk of worsening.

Active Moderate-to-Severe Disease

This group generally requires:

Disease-modifying therapy

rather than observation alone.

Modern treatment options include:

• IV glucocorticoids
• Mycophenolate
• Teprotumumab
• Orbital radiotherapy
• Selected biologic therapy

Choice varies by:

• Disease phenotype
• Availability
• Comorbidities
• Regional guidelines

Intravenous Glucocorticoids

IV methylprednisolone is generally more effective and better tolerated than prolonged high-dose oral steroids for active moderate-to-severe TED.

A commonly used regimen delivers repeated weekly pulses with a total cumulative dose around:

4.5 g

for standard moderate-to-severe active disease.

Exact protocols vary.

Why Very High Steroid Doses Are Avoided

Large cumulative IV methylprednisolone doses increase the risk of:

• Acute liver injury
• Cardiovascular events
• Infection
• Hyperglycemia
• Psychiatric complications

Cumulative doses above approximately:

8 g per treatment course

are generally avoided except in exceptional circumstances.

Mycophenolate

Modern European-style regimens often combine:

IV methylprednisolone + mycophenolate

for active moderate-to-severe disease.

Mycophenolate can:

• Improve inflammatory control
• Reduce relapse
• Reduce steroid exposure

depending on the clinical phenotype.

Teprotumumab

A major modern advance is:

Teprotumumab

a monoclonal antibody targeting:

IGF-1R

It can improve:

• Proptosis
• Diplopia
• Soft-tissue inflammation
• Quality of life

and is particularly attractive when proptosis is a major feature.

Important Teprotumumab Adverse Effects

Potential adverse effects include:

• Hearing impairment
• Hyperglycemia
• Muscle spasm
• Nausea
• Alopecia
• Fatigue
• Infusion reactions

Hearing effects can occasionally persist.

Patients may require:

• Baseline auditory assessment
• Audiologic monitoring
• Glucose monitoring

Pregnancy and Teprotumumab

Teprotumumab can interfere with fetal growth signaling and is:

Contraindicated in pregnancy.

Appropriate pregnancy avoidance is required during treatment and for the recommended period afterward.

Other Biologic or Targeted Options

Selected refractory active disease may be treated with:

• Tocilizumab
• Rituximab

Tocilizumab may be particularly useful in:

Steroid-resistant active TED.

Rituximab evidence is mixed and patient selection is important.

Orbital Radiotherapy

Orbital radiotherapy may improve:

• Active extraocular muscle inflammation
• Restrictive motility
• Diplopia

A common regimen is approximately:

20 Gy divided over 10 fractions

although lower-dose protocols are also used.

Where Radiotherapy Works Best

Radiotherapy tends to be most useful for:

• Active motility restriction
• Inflammatory muscle disease

It is less effective for established:

• Proptosis
• Fibrotic lid retraction

It may be combined with corticosteroids.

When Radiotherapy Is Avoided or Used Cautiously

Caution is appropriate in:

• Younger patients
• Diabetic retinopathy
• Severe hypertension
• Other retinal microvascular disease

because of potential radiation-related ocular complications.

Sight-Threatening Optic Neuropathy

DON requires:

Immediate treatment.

Initial therapy generally consists of:

High-dose IV methylprednisolone

provided there is no major contraindication.

When Orbital Decompression Becomes Urgent

If vision does not improve adequately or promptly after IV steroids, or steroids are contraindicated:

Urgent orbital decompression

is indicated.

Waiting for the disease to become inactive is inappropriate when the optic nerve is threatened.

Corneal Breakdown as a Sight-Threatening Emergency

Severe exposure can cause:

• Persistent epithelial defect
• Ulceration
• Stromal thinning
• Perforation

Treatment may include:

• Intensive lubrication
• Moisture chamber
• Bandage or scleral lens in selected cases
• Temporary tarsorrhaphy
• Eyelid procedure
• Orbital decompression if severe proptosis prevents closure

Rehabilitative Surgery

Once inflammatory disease is inactive and measurements are stable, reconstructive surgery generally follows this sequence:

Orbital decompression → strabismus surgery → eyelid surgery

The order matters because each step can alter the next.

Orbital Decompression

Decompression creates additional orbital volume by removing:

• Bone
• Orbital fat
• Both

Potential walls include:

• Medial wall
• Floor
• Lateral wall

The approach depends on:

• Proptosis severity
• DON
• Pre-existing diplopia
• Surgeon preference

Why Balanced Decompression Is Used

Removing both medial and lateral walls can reduce proptosis while attempting to minimize:

New-onset diplopia

compared with some asymmetric decompression strategies.

No single decompression technique is best for every patient.

Complications of Orbital Decompression

Possible complications include:

• New or worsened diplopia
• Infraorbital numbness
• Sinus complications
• CSF leak, rarely
• Globe displacement
• Vision-threatening hemorrhage, rarely

Strabismus Surgery

Strabismus surgery is usually performed only after:

• Disease is inactive
• Measurements are stable

The goal is mainly to provide single binocular vision in:

• Primary gaze
• Reading position

Perfect single vision in all gaze directions is often unrealistic.

Why Recession Is Common

Restrictive muscles are usually:

Recessed rather than resected

because the problem is excessive tightness rather than weakness.

Adjustable sutures are often useful.

Eyelid Surgery

After orbital and strabismus correction, persistent lid retraction can be treated surgically.

Options include:

• Upper-lid levator/Müller muscle recession
• Lower-lid retractor recession
• Spacer grafts in selected lower-lid cases
• Blepharoplasty when appropriate

Goals include:

• Better corneal protection
• Improved symmetry
• Improved appearance

Timing of Reconstructive Surgery

Elective reconstructive surgery is generally delayed until:

TED has become inactive and measurements have been stable for several months.

The exception is surgery required urgently for:

• Optic neuropathy
• Severe corneal exposure

Monitoring Over Time

Follow-up frequency depends on severity.

During active disease, monitor:

• Visual acuity
• Color vision
• Pupils
• CAS/inflammatory signs
• Proptosis
• Motility
• Diplopia
• Corneal exposure
• IOP
• Optic nerve status

Rapidly changing disease may require review every:

Few weeks or sooner.

Signs Requiring Urgent Review

Patients should seek prompt assessment for:

• Reduced vision
• Faded colors
• New visual-field defect
• Rapidly worsening proptosis
• Increasing diplopia
• Severe exposure
• Corneal pain
• Inability to close the eyelids

These may indicate:

• DON
• Corneal ulceration
• Rapid disease progression

Expected Clinical Course

Most patients have:

Mild disease

requiring mainly:

• Observation
• Lubrication
• Risk-factor modification

A smaller group develops:

• Persistent diplopia
• Disfiguring proptosis
• Significant lid retraction

Only a small minority develop:

Sight-threatening disease.

Factors Associated With Worse Disease

Poorer outcomes are associated with:

• Smoking
• Older age
• Male sex
• Poor thyroid control
• High autoantibody levels
• Diabetes
• Delayed recognition of optic neuropathy

Potential Complications

Important complications include:

• Dysthyroid optic neuropathy
• Exposure keratopathy
• Corneal ulceration or perforation
• Persistent diplopia
• Restrictive strabismus
• Ocular hypertension
• Disfigurement
• Steroid-induced cataract
• Steroid-induced glaucoma
• Treatment-related hearing loss with teprotumumab

High-Yield Takeaways

• Thyroid eye disease is an autoimmune orbital disorder affecting extraocular muscles, orbital fat, connective tissue, eyelids, and the ocular surface.
• TED can occur in hyperthyroid, hypothyroid, or euthyroid patients.
• Upper-lid retraction is the most characteristic external sign.
• The most important modifiable risk factor is smoking, which increases disease risk, severity, treatment resistance, and risk of worsening after radioactive iodine.
• Modern pathogenesis involves both TSH receptor and IGF-1 receptor signaling in orbital fibroblasts.
• The typical imaging finding is extraocular muscle belly enlargement with relative tendon sparing, especially involving the inferior and medial recti.
• TED causes restrictive rather than paralytic strabismus; inferior rectus restriction commonly limits elevation.
• Always assess visual acuity, pupils, color vision, motility, corneal exposure, proptosis, and optic nerve function.
• Dysthyroid optic neuropathy can occur without dramatic proptosis and may have a normal-appearing optic disc.
• CAS is useful for measuring inflammation, but activity should not be determined from CAS alone.
• Mild disease usually requires smoking cessation, euthyroidism, lubrication, and observation; selenium may help selected patients with mild active disease.
• Active moderate-to-severe disease may be treated with IV glucocorticoids, often with mycophenolate, teprotumumab, orbital radiotherapy, or selected biologic therapy.
• Teprotumumab targets IGF-1R and can markedly reduce proptosis and diplopia, but important adverse effects include hearing impairment and hyperglycemia.
• Very high cumulative IV methylprednisolone doses should be avoided because of serious hepatic and cardiovascular toxicity.
• Dysthyroid optic neuropathy is an emergency requiring high-dose IV corticosteroids and urgent decompression if response is inadequate.
• Severe corneal exposure with ulceration is also sight-threatening and requires immediate surface protection.
• Elective rehabilitative surgery usually follows the sequence orbital decompression → strabismus surgery → eyelid surgery after disease becomes inactive.
• Radioactive iodine can worsen TED in susceptible patients; glucocorticoid prophylaxis may be indicated when RAI is necessary.
• Most TED is mild, but early recognition of optic neuropathy and corneal compromise is critical to preventing permanent visual loss.

Ophthalmology – Thygeson’s Superficial Punctate Keratitis

What the Disorder Represents

Thygeson’s superficial punctate keratitis (TSPK) is a rare, chronic, recurrent corneal epithelial disorder characterized by multiple:

• Gray-white
• Coarse
• Slightly elevated
• Intraepithelial corneal lesions

The classic disease has:

• Little or no conjunctival injection
• No significant stromal inflammation
• No corneal edema
• No anterior chamber inflammation

It is usually:

Bilateral but frequently asymmetric.

Who Develops It

TSPK can occur at almost any age.

It most often presents in:

• Children
• Young adults
• Middle-aged adults

There is no strong consistent sex predilection.

The condition is:

Uncommon.

Why It Develops

The exact cause remains:

Unknown.

An immune-mediated mechanism is favored because:

• Lesions respond dramatically to corticosteroids
• Topical immunomodulators can suppress recurrences
• Disease follows a relapsing-remitting course

A viral trigger has historically been proposed, but:

No specific infectious agent has been established.

HLA Association

An association with:

HLA-DR3

has been reported.

However, HLA testing has:

No role in routine diagnosis or management.

What Patients Usually Notice

Symptoms vary considerably.

Common complaints include:

• Foreign-body sensation
• Mild to moderate irritation
• Photophobia
• Tearing
• Burning
• Fluctuating or mildly blurred vision

Some patients have surprisingly prominent photophobia despite limited slit-lamp findings.

Others may be:

Almost asymptomatic.

Typical Visual Acuity

Visual acuity is often:

• Normal
• Mildly reduced

More significant blur occurs when lesions involve the:

Central visual axis.

Permanent reduction in vision is unusual.

The Classic Slit-Lamp Appearance

The hallmark is:

Multiple discrete gray-white granular epithelial lesions with normal intervening cornea.

Lesions are typically:

• Small
• Round or oval
• Coarse
• Slightly raised
• Centrally or paracentrally distributed

The intervening corneal epithelium is generally:

Clear and relatively normal.

How the Lesions Stain

Lesions may show:

• Minimal fluorescein staining
• Fine punctate staining
• No staining at all

Prominent epithelial ulceration is:

Not typical.

Where the Lesions Are Located

TSPK predominantly affects the:

Corneal epithelium

with possible involvement of the very superficial subepithelial region.

There should not be significant:

• Stromal infiltrate
• Stromal edema
• Endothelial involvement

What the Conjunctiva Looks Like

The conjunctiva is characteristically:

Quiet or only minimally injected.

This is a useful clue because many infectious and inflammatory keratitides produce much more conspicuous conjunctival inflammation.

What Should Not Be Present

Classic TSPK should not produce:

• Significant mucopurulent discharge
• Stromal suppuration
• Corneal thinning
• Anterior chamber cells
• Hypopyon
• Marked conjunctivitis

If these are present, reconsider the diagnosis.

How the Disease Evolves

Individual lesions may:

• Appear
• Fade
• Disappear
• Recur elsewhere

The disease commonly follows a:

Relapsing-remitting course lasting years.

Patients may have long symptom-free intervals between flares.

How the Diagnosis Is Made

TSPK is primarily a:

Clinical diagnosis

based on:

1. Characteristic epithelial lesions
2. Minimal conjunctival inflammation
3. Bilateral or asymmetric recurrent course
4. Absence of stromal or anterior chamber disease

No routine laboratory testing is necessary.

Is Corneal Scraping Usually Needed?

No.

Corneal cultures or scrapings are unnecessary in typical TSPK.

They should be considered when findings are atypical and infection is suspected, such as:

• Significant pain
• Stromal infiltrate
• Epithelial ulcer
• Contact lens-associated keratitis
• Anterior chamber inflammation

Role of Slit-Lamp Photography

Photography can be useful for:

• Documenting baseline disease
• Comparing recurrent episodes
• Teaching purposes

but is not needed to establish the diagnosis.

Role of Confocal Microscopy

In vivo confocal microscopy may demonstrate epithelial and subepithelial abnormalities, but it is primarily:

A research or adjunctive tool

rather than a routine diagnostic test.

Important Diagnostic Mimics

The differential diagnosis includes:

• Adenoviral keratoconjunctivitis
• Dry eye-related superficial punctate keratitis
• Toxic medicamentosa
• Contact lens-related epithelial disease
• Early infectious keratitis
• Recurrent corneal erosion
• Exposure keratopathy
• Thygeson-like lesions from other causes

Distinguishing It From Adenoviral Keratitis

Adenoviral keratoconjunctivitis typically has:

• Marked conjunctival injection
• Follicular conjunctivitis
• Preauricular lymphadenopathy
• Recent contagious red-eye illness

Later adenoviral disease may leave:

Subepithelial infiltrates

that can resemble TSPK.

TSPK instead usually has:

• Quiet conjunctiva
• Recurrent epithelial lesions
• No preceding acute conjunctivitis

Distinguishing It From Dry Eye Disease

Dry eye usually causes:

• Diffuse punctate epithelial staining
• Interpalpebral distribution
• Tear-film abnormalities
• Conjunctival staining

TSPK produces:

Discrete coarse gray-white epithelial lesions with clear intervening cornea.

Distinguishing It From Infectious Keratitis

Bacterial or fungal keratitis typically shows:

• Focal stromal infiltrate
• Epithelial defect
• Significant pain
• Conjunctival injection
• Possible anterior chamber reaction

These findings should not be attributed to uncomplicated TSPK.

First Approach in Mild Disease

If the patient has:

• Few lesions
• Minimal symptoms
• Good vision

management may consist of:

Observation and lubrication.

Preservative-free artificial tears can reduce:

• Irritation
• Foreign-body sensation

Most Effective Treatment for Symptomatic Flares

The traditional and most rapidly effective treatment is:

A low-potency topical corticosteroid

Examples include:

• Fluorometholone
• Loteprednol

Treatment usually produces rapid improvement in:

• Symptoms
• Corneal lesions

Why Potent Steroids Are Usually Unnecessary

TSPK is generally highly steroid-responsive.

Therefore the goal is to use:

The lowest potency and frequency necessary to control symptoms

rather than prolonged high-dose corticosteroid treatment.

Why the Steroid Taper Must Be Slow

Recurrence commonly occurs when topical corticosteroids are stopped abruptly.

A typical strategy is:

Gradual taper over weeks to months

Some patients eventually require very infrequent maintenance dosing.

Risks of Long-Term Steroid Therapy

Repeated or prolonged corticosteroid use can cause:

• Ocular hypertension
• Steroid-induced glaucoma
• Posterior subcapsular cataract
• Increased susceptibility to infection

Therefore IOP should be monitored during extended treatment.

Steroid-Sparing Treatment

Topical immunomodulators are particularly useful for:

• Frequent recurrences
• Steroid dependence
• Steroid responders
• Long-term disease

Common options include:

Topical cyclosporine

and, in selected cases:

Topical tacrolimus.

Role of Cyclosporine

Topical cyclosporine can:

• Reduce symptoms
• Suppress recurrent lesions
• Reduce dependence on corticosteroids

Its effect is usually:

Slower than topical steroid therapy

so it is more useful for long-term disease control than immediate relief.

Role of Tacrolimus

Topical tacrolimus has also been reported to control recurrent TSPK, particularly when:

• Steroids cannot be used safely
• Cyclosporine is inadequate or poorly tolerated

Use is typically under corneal specialist supervision.

Therapeutic Contact Lenses

A soft bandage contact lens can occasionally reduce symptoms by shielding the corneal epithelium.

However, this is not routine first-line therapy because contact lenses introduce risks such as:

• Microbial keratitis
• Hypoxia
• Lens-related inflammation

They are generally reserved for:

Selected refractory symptomatic cases.

Are Antiviral Drugs Useful?

Older reports investigated agents such as:

• Trifluridine
• Idoxuridine

These are:

Not standard modern therapy for TSPK.

There is no established viral etiology requiring routine antiviral treatment.

Important Modern Correction About Idoxuridine

Idoxuridine is obsolete for this indication and can produce significant:

Corneal epithelial toxicity.

It should not be used to treat TSPK.

Does Steroid Treatment Prolong the Disease?

Older literature suggested that corticosteroids might prolong the total disease course.

This remains uncertain.

The clinically important point is that corticosteroids:

• Relieve symptoms rapidly
• Suppress lesions effectively
• Do not cure the underlying tendency to recur

Therefore treatment should focus on:

Symptom control with minimum long-term steroid exposure.

Refractive Surgery Considerations

TSPK has been reported to recur after:

• LASIK
• PRK

Elective corneal refractive surgery should generally be deferred while disease is:

Active or unstable.

An Important Correction About LASIK vs PRK

Older case reports suggested a lower recurrence risk after PRK than LASIK.

There is:

Insufficient evidence to consider PRK reliably safer than LASIK specifically for TSPK.

The more important principle is to operate only after a prolonged period of:

Stable ocular surface disease.

When Specialist Referral Is Useful

Corneal specialist evaluation is appropriate when:

• Diagnosis is uncertain
• Lesions are atypical
• Disease is unilateral and persistent
• The patient becomes steroid-dependent
• IOP rises with treatment
• Symptoms persist despite appropriate therapy

Monitoring During Treatment

Follow-up should assess:

• Visual acuity
• Number and location of corneal lesions
• Symptoms
• Corneal staining
• IOP when steroids are being used

There is no single follow-up interval appropriate for every patient.

Expected Long-Term Course

TSPK may recur intermittently for:

Several years or even decades

but eventually tends to become less active in many patients.

The disease generally does not produce progressive destructive corneal disease.

Visual Prognosis

Long-term visual prognosis is:

Excellent.

Most patients do not develop:

• Significant corneal scarring
• Stromal opacity
• Permanent visual loss

Visual disturbance during active episodes is usually reversible.

Potential Problems During Management

The disease itself rarely causes serious complications.

Most clinically important complications relate to therapy, particularly:

• Steroid-induced ocular hypertension
• Glaucoma
• Cataract
• Contact lens-related infection

High-Yield Takeaways

• Thygeson’s superficial punctate keratitis is a chronic, recurrent epithelial keratitis characterized by multiple coarse gray-white slightly elevated corneal lesions.
• It is usually bilateral but asymmetric.
• The conjunctiva is characteristically quiet or minimally injected.
• There is usually no stromal inflammation, corneal edema, or anterior chamber reaction.
• Symptoms include foreign-body sensation, irritation, photophobia, and mild fluctuating blur.
• The diagnosis is clinical; laboratory testing, cultures, and imaging are unnecessary in typical cases.
• The most important mimics include adenoviral subepithelial keratitis, dry eye, toxic keratopathy, and infectious keratitis.
• Mild or asymptomatic disease can be managed with observation and preservative-free lubrication.
• Symptomatic flares respond rapidly to low-potency topical corticosteroids, usually followed by a very gradual taper.
• Long-term corticosteroid use requires monitoring for ocular hypertension, glaucoma, and cataract.
• Topical cyclosporine is an important steroid-sparing option for recurrent or steroid-dependent disease; tacrolimus may be useful in selected cases.
• Routine antiviral treatment is not indicated, because a specific viral cause has never been established.
• Idoxuridine is obsolete and potentially toxic to the corneal epithelium.
• Elective corneal refractive surgery should generally be avoided during active disease; there is insufficient evidence that PRK reliably prevents recurrence compared with LASIK.
• TSPK often follows a relapsing-remitting course over many years, but permanent corneal scarring or significant long-term visual loss is uncommon.
• Overall visual prognosis is excellent.

Ophthalmology – Talc Retinopathy

What the Disorder Represents

Talc retinopathy is a crystalline embolic retinopathy classically associated with intravenous injection of crushed oral medications containing insoluble tablet excipients.

The characteristic fundus finding is:

Multiple tiny, glistening white-yellow refractile particles lodged within retinal vessels and the inner retina.

Most patients initially retain good vision, but extensive embolization may produce:

• Retinal capillary nonperfusion
• Macular ischemia
• Retinal neovascularization
• Vitreous hemorrhage
• Fibrovascular proliferation
• Tractional retinal detachment

A More Accurate Modern Concept

The historical term “talc retinopathy” implies that the embolic material is always talc.

In contemporary practice, injected tablets may contain several insoluble excipients, including:

• Talc
• Microcrystalline cellulose
• Starch
• Other particulate fillers

Therefore the broader concept is:

Particulate embolic retinopathy from intravenous injection of crushed oral medications.

Talc remains the classic name and histopathologic association.

How the Retinal Deposits Develop

Oral tablets are manufactured for gastrointestinal absorption, not intravenous administration.

When crushed tablets are injected intravenously, insoluble particles can enter the circulation and embolize to small vessels.

Particles initially lodge predominantly within:

Pulmonary arterioles and capillaries

and may produce:

• Pulmonary foreign-body granulomatosis
• Pulmonary hypertension
• Chronic lung disease

Particles reaching the systemic circulation can embolize to organs including the retina.

How Particles Reach the Eye

Older descriptions suggested that chronic pulmonary vascular injury creates collateral pathways that allow particulate material into the systemic circulation.

The precise route is not always established.

Possible mechanisms include:

• Passage of very small particles through the pulmonary microcirculation
• Pulmonary arteriovenous shunting
• Intracardiac right-to-left shunting
• Altered pulmonary vascular pathways after repeated embolization

The essential mechanism is:

Systemic embolization of insoluble injected material into the retinal microcirculation.

Where the Particles Lodge

Particles are found predominantly within:

• Retinal arterioles
• Precapillary arterioles
• Capillary beds
• Inner retinal tissue adjacent to vessels

They are often especially conspicuous in the:

Posterior pole.

Why Retinal Ischemia Can Develop

Repeated particulate embolization may obstruct retinal microvasculature.

Chronic vascular occlusion can lead to:

Capillary nonperfusion → retinal ischemia → VEGF production → retinal or disc neovascularization

This resembles the final common pathway of other proliferative ischemic retinopathies.

Who Is at Risk

The classic risk factor is:

Intravenous injection of crushed oral tablets

Historically implicated medications include:

• Methylphenidate
• Methadone
• Pentazocine
• Other crushed prescription tablets

The exact medication is less important than the presence of:

Insoluble particulate excipients injected intravenously.

What the Patient May Report

Many patients are initially:

Asymptomatic

because the deposits themselves do not necessarily impair central vision.

Symptoms may develop when complications occur and include:

• Blurred vision
• Floaters
• Reduced central vision
• Scotoma
• Sudden visual loss from vitreous hemorrhage

Why the History Can Be Difficult

A history of injected crushed medications may not initially be volunteered.

The examiner may need to ask specifically about:

• Intravenous drug use
• Injection of crushed tablets
• Previous substance use
• Pulmonary symptoms

The retinal appearance may occasionally provide the first clue to previously undisclosed exposure.

Characteristic Fundus Appearance

The hallmark is:

Numerous tiny, highly refractile white or yellow-white particles

distributed along:

• Retinal arterioles
• Small vessels
• Capillary beds

They are often most prominent around the:

• Macula
• Posterior pole

but may extend throughout the retina.

Why the Deposits Look Crystalline

The particles strongly reflect incident light, giving them a:

• Bright
• Glistening
• Sparkling

appearance.

They can resemble other forms of crystalline retinopathy but their:

Intravascular or perivascular distribution

is an important clue.

Early Retinal Changes

In mild disease, the only abnormality may be:

• Scattered refractile particles

with:

• Normal visual acuity
• Minimal vascular disturbance
• No neovascularization

Such cases may remain stable for years if exposure stops.

Ischemic Retinal Changes

More advanced disease may show:

• Capillary nonperfusion
• Cotton-wool spots
• Microaneurysms
• Venous abnormalities
• Vascular remodeling
• Areas of retinal ischemia

These findings indicate more extensive microvascular injury.

Proliferative Talc Retinopathy

Severe ischemia can result in:

• Neovascularization of the disc
• Neovascularization elsewhere
• Fibrovascular proliferation

This may progress to:

• Vitreous hemorrhage
• Tractional retinal detachment

Macular Involvement

Vision can be reduced by:

• Macular ischemia
• Macular fibrosis
• Epiretinal or fibrovascular tissue
• Rare macular edema
• Traction involving the macula

Macular ischemia may cause permanent visual loss despite a relatively quiet fundus.

Fluorescein Angiography

FA is useful when significant vascular disease is suspected.

It can demonstrate:

• Capillary nonperfusion
• Delayed retinal perfusion
• Microvascular abnormalities
• Leakage from retinal neovascularization
• Disc neovascularization

Wide-field FA is particularly helpful when peripheral ischemia is suspected.

Optical Coherence Tomography

OCT may demonstrate:

• Small hyperreflective intraretinal deposits
• Inner retinal structural abnormalities
• Macular thinning from ischemia
• Fibrotic or tractional changes

It is particularly useful for assessing:

Macular involvement and secondary structural complications.

OCT Angiography

OCTA can demonstrate:

• Reduced capillary density
• Areas of capillary dropout
• Macular ischemia
• Abnormal neovascular networks

It is noninvasive but does not demonstrate:

Vascular leakage

and therefore complements rather than completely replaces FA.

Fundus Photography

Color or ultra-widefield photography is useful for:

• Documenting crystalline deposits
• Comparing disease over time
• Monitoring ischemic or proliferative complications

The refractile particles may remain visible for many years.

Systemic Clues

Because injected particulates frequently affect the lungs, patients may also have:

• Dyspnea
• Chronic cough
• Exercise intolerance
• Pulmonary hypertension

Chronic particulate embolization can produce:

Pulmonary foreign-body granulomatosis or talcosis.

Why Systemic Evaluation Matters

Talc retinopathy may represent only one manifestation of widespread particulate embolization.

Depending on the history and symptoms, patients may need assessment for:

• Pulmonary disease
• Infectious complications of intravenous drug use
• Cardiovascular complications
• Substance-use disorder

Important Conditions That Mimic It

The differential diagnosis includes other crystalline or refractile retinal disorders such as:

• Tamoxifen retinopathy
• Canthaxanthin retinopathy
• Bietti crystalline dystrophy
• Cystinosis
• Calcified drusen
• Macular telangiectasia type 2
• Intraretinal hard exudates
• Cholesterol emboli

Distinguishing It From Hollenhorst Plaques

Talc Retinopathy

• Numerous tiny crystals
• Distributed throughout small retinal vessels
• Often bilateral
• Associated with particulate intravenous exposure

Hollenhorst Plaque

• Usually a larger yellow-orange refractile embolus
• Located at an arterial bifurcation
• Typically originates from carotid or aortic atherosclerosis

A Hollenhorst plaque should trigger:

Systemic vascular evaluation, not a diagnosis of talc retinopathy.

Distinguishing It From Tamoxifen Retinopathy

Tamoxifen may produce:

• Bilateral parafoveal crystalline deposits
• Macular cavitations
• Outer retinal changes

The crystals are usually centered around the macula rather than appearing as widespread:

Intravascular particulate emboli.

Medication history is critical.

Distinguishing It From Canthaxanthin Retinopathy

Canthaxanthin classically produces:

• Symmetric golden crystalline deposits
• Ring-like distribution around the macula

The deposits are not characteristically concentrated in retinal vessels.

Distinguishing It From Bietti Crystalline Dystrophy

Bietti crystalline dystrophy is inherited and usually causes:

• Numerous retinal crystals
• Progressive chorioretinal atrophy
• Night-vision or field abnormalities
• Peripheral retinal degeneration

It is unrelated to intravenous particulate exposure.

Distinguishing It From Macular Telangiectasia Type 2

MacTel type 2 may show:

• Parafoveal crystalline deposits
• Temporal foveal graying
• Right-angled vessels
• Cavitary OCT changes

but does not produce the characteristic widespread:

Embolic vascular distribution.

First Management Priority

The most important intervention is:

Stopping further intravenous injection of crushed tablets or other particulate material.

Continued exposure increases the risk of:

• Progressive retinal ischemia
• Pulmonary damage
• Systemic complications

Addressing Substance Use

Patients should be offered nonjudgmental access to:

• Addiction medicine
• Harm-reduction services
• Mental-health support
• Medication-assisted treatment when appropriate

The objective is to prevent both ocular and systemic injury.

Management of Mild Disease

If the patient has:

• Preserved vision
• No significant capillary nonperfusion
• No retinal neovascularization

management is usually:

Observation

with documentation of the retinal findings.

There is no treatment that removes existing talc particles from the retina.

Managing Retinal Ischemia

Patients with substantial capillary nonperfusion require closer observation for development of:

Neovascularization.

The presence of ischemia alone does not necessarily mandate immediate laser treatment unless proliferative complications develop or the ischemic burden is considered sufficiently high by the treating retinal specialist.

Panretinal Photocoagulation

When retinal ischemia produces:

• Neovascularization of the disc
• Neovascularization elsewhere

Panretinal photocoagulation (PRP) is appropriate to reduce the angiogenic drive.

Role of Anti-VEGF Therapy

Intravitreal anti-VEGF can be considered as an adjunct when significant:

• Retinal neovascularization
• Neovascular complications

are present.

However:

Anti-VEGF does not correct the underlying capillary nonperfusion or remove particulate emboli.

PRP provides more durable treatment for extensive ischemic proliferative disease when feasible.

When Vitrectomy Is Needed

Pars plana vitrectomy may be indicated for:

• Nonclearing vitreous hemorrhage
• Tractional retinal detachment
• Macula-threatening traction
• Dense fibrovascular proliferation

Surgery addresses complications rather than the underlying deposited particles.

Follow-Up Strategy

Follow-up depends on severity.

Patients with mild stable deposits and no significant ischemia may be monitored periodically.

More frequent retinal review is appropriate when there is:

• Capillary nonperfusion
• Neovascularization
• Vitreous hemorrhage
• Traction
• Continued particulate exposure

A fixed annual schedule is therefore not appropriate for every patient.

Can the Crystals Disappear?

The deposited particles may remain visible:

Indefinitely

even after intravenous exposure stops.

Persistence of crystals does not necessarily mean disease remains active.

Progression depends more on:

• Continued embolization
• Degree of accumulated vascular injury
• Extent of retinal ischemia

Expected Clinical Course

After cessation of exposure, uncomplicated talc retinopathy may remain:

Relatively static

for prolonged periods.

However, established ischemic or fibrotic damage may be irreversible.

Continued intravenous particulate exposure can cause progressive vascular injury.

Factors That Determine Vision

Visual prognosis depends primarily on whether there is:

• Macular ischemia
• Vitreous hemorrhage
• Macular fibrosis
• Tractional retinal detachment
• Other drug-related or infectious ocular complications

The number of visible crystals alone does not necessarily predict visual acuity.

Potential Ocular Complications

Complications include:

• Retinal capillary nonperfusion
• Retinal ischemia
• Disc neovascularization
• Retinal neovascularization
• Vitreous hemorrhage
• Preretinal fibrosis
• Tractional retinal detachment
• Macular ischemia
• Permanent visual loss

High-Yield Takeaways

• Talc retinopathy is a particulate embolic retinopathy classically associated with intravenous injection of crushed oral tablets.
• The characteristic finding is numerous tiny, glistening white-yellow refractile particles within or immediately adjacent to retinal vessels, particularly in the posterior pole.
• The embolic material is not necessarily talc; microcrystalline cellulose and other tablet fillers can produce a similar retinopathy.
• Repeated particulate embolization can cause capillary occlusion and retinal ischemia.
• Mild disease may consist only of crystals with preserved visual acuity.
• Severe disease may produce capillary nonperfusion, disc or retinal neovascularization, vitreous hemorrhage, fibrosis, and tractional retinal detachment.
• Fluorescein angiography, particularly wide-field FA, is useful for assessing retinal nonperfusion and neovascularization.
• OCT evaluates macular ischemic, fibrotic, and tractional complications; OCTA can demonstrate capillary dropout without showing leakage.
• Important mimics include tamoxifen retinopathy, canthaxanthin retinopathy, Bietti crystalline dystrophy, MacTel type 2, and cholesterol emboli.
• Talc retinopathy may coexist with serious pulmonary particulate embolic disease, including foreign-body granulomatosis and pulmonary hypertension.
• The fundamental treatment is cessation of intravenous particulate exposure and appropriate substance-use treatment/support.
• There is no therapy that removes established retinal crystals.
• Asymptomatic nonproliferative disease can usually be observed.
• PRP is indicated when ischemia leads to clinically significant retinal or disc neovascularization.
• Anti-VEGF may be used as an adjunct for neovascular complications but does not treat the underlying retinal nonperfusion.
• Vitrectomy is appropriate for nonclearing vitreous hemorrhage or tractional retinal detachment.
• After exposure stops, the retinopathy may remain stable despite persistent visible crystals, while continued injection increases the risk of progressive retinal and systemic injury.